Abstract
The single-celled baker’s yeast, Saccharomyces cerevisiae, can sustain a number of amyloid-based prions, the three most prominent examples being [URE3], [PSI+], and [PIN+]. In the laboratory, haploid S. cerevisiae cells of a single mating type can acquire an amyloid prion in one of two ways (i) spontaneous nucleation of the prion within the yeast cell, and (ii) receipt via mother-to-daughter transmission during the cell division cycle. Similarly, prions can be lost due to (i) dissolution of the prion amyloid by its breakage into non-amyloid monomeric units, or (ii) preferential donation/retention of prions between the mother and daughter during cell division. Here we present a computational tool (Monitoring Induction and Loss of prions in Cells; MIL-CELL) for modelling these four general processes using a multiscale approach describing both spatial and kinetic aspects of the yeast life cycle and the amyloid-prion behavior. We describe the workings of the model, assumptions upon which it is based and some interesting simulation results pertaining to the wave-like spread of the epigenetic prion elements through the yeast population. MIL-CELL is provided as a stand-alone GUI executable program for free download with the paper. MIL-CELL is equipped with a relational database allowing all simulated properties to be searched, collated and graphed. Its ability to incorporate variation in heritable properties means MIL-CELL is also capable of simulating loss of the isogenic nature of a cell population over time. The capability to monitor both chronological and reproductive age also makes MIL-CELL potentially useful in studies of cell aging.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
MIL-CELL is a sophisticated point-and-click software that is capable of simulating variable yeast growth and division along with the formation and passage of amyloid prion epigenetic factors from mother to daughter cells. The first yeast epigenetic factor to be identified as an amyloid prion was [URE3] for which the fiber component is assembled via polymerization of the Ure2p protein (a regulator of nitrogen metabolism) (Wickner 1994; Masison et al 1997; King et al. 1997; Wickner et al. 1999). Since that time numerous other yeast amyloid prions have been discovered, with the two most notable examples being [PSI+] (amyloid generated from the Sup35 protein, a yeast translation termination release factor) (Wickner 1994; Patino et al. 1996; Paushkin et al. 1996; Derkatch et al. 1996) and [PIN+] (amyloid assembled from the Rnq1 protein, of unknown function) (Derkatch et al. 1996, 2000; Sondheimer and Lindquist 2000). Relatively recently, researchers have taken up the challenge of producing biophysical models of amyloid growth in yeast (Tanaka et al. 2006; Lemarre et al. 2020; Banwarth-Kuhn and Sindi 2020). Whilst successful in their specified aims, these models have neglected certain important physical aspects related to the (i) effects of spatial arrangement of the growing cells within the colony on the dispersion of amyloid amongst the yeast, (ii) biochemical mechanism of amyloid growth and transfer between yeast and nascent daughter, and (iii) the biochemical and physical determinants of the colony screen. The aim of the current work was to develop an informative biophysical model of amyloid formation and cytosolic transfer in dividing yeast that could usefully comment on these previously neglected features (Tanaka et al. 2006; Lemarre et al. 2020; Banwarth-Kuhn and Sindi 2019; Banwarth-Kuhn et al. 2020). To help orient the reader a short history of the study of amyloid prion growth and transmission in yeast is provided. After setting this introductory foundation the theoretical basis of the model is developed and then used to simulate some interesting situations of yeast carrying and passing on amyloid prions to their offspring. The paper concludes with a short description of the usage of the MIL-CELL program and highlights its potential future applications for the study of amyloid prion-based epigenetic transfer along with other areas related to amyloidosis, cancer and aging.
A short history of the study of amyloid/prions in Saccharomyces cerevisiae
Although Saccharomyces cerevisiae (bakers’ yeast) is a unicellular eukaryotic organism, it shares many genetic and biochemical pathways in common with more complex multi-cellular eukaryotes (including humans), and for this reason it has become a key model system (Karathia et al. 2011; Duina et al. 2014). Despite being regarded as relatively simple, S. cerevisiae nevertheless, exhibits a complex life-cycle, that is capable of mitotic reproduction from two vegetative states of different ploidy (yeast budding from both the haploid and diploidFootnote 1 states), meiotic cell division (yeast sporulation) from its diploid form, and sexual reproduction (yeast mating) between the different sexes (a and α) of haploid yeast states (Duina et al. 2014) (Fig. 1). Due to its approximately 90-min reproduction time and an abundance of yeast specific biochemical and genetic experimental tools, S. cerevisiae, has been pivotal to the development of our modern scientific understanding of the eukaryotic cell cycleFootnote 2 (Hartwell 1974; Hartwell and Unger 1977; Forsburg and Nurse 1991). From a number of somewhat initially confounding genetic studies a series of epigenetic factorsFootnote 3 were identified in yeast (Riggs et al. 1996; Bonasio et al. 2010) and the study of the non-chromosomal DNA sequence-related origins of such epigenetic factors helped to spawn important fields of research such as DNA methylationFootnote 4 (Singal and Ginder 1999; Weissbach 2013), histone post-translational modification (Davie et al. 1981; O’Kane and Hyland 2019), transposon biology (Zou et al. 1996; Hosaka and Kakutani 2018), mitochondrial gene replication (Rasmussen et al. 2003) and the cytosolic localization of both dsRNA virus-like genomes (Wickner and Leibowitz 1977) and yeast DNA plasmids (Gunge 1983). Within such a diverse background of non-chromosomal DNA sequence-based epigenetic factors there were two particular phenotypic traits, [URE3]—associated with catabolism of uredosuccinic acid as a potential yeast food source (Lacroute 1971; Aigle and Lacroute 1975), and [PSI+]—associated with the suppression of nonsense genes produced by translation past a stop codon (Cox 1965; Serio et al. 1999), which proved enigmatic and resisted easy assignment to any of the above noted epigenetic causes (Tuite et al. 2015).
Adapting concepts developed in the field of Scrapie biology (Prusiner 1982), Reed Wickner proposed a paradigm-shifting ‘protein only’ epigenetic mechanism for the [URE3] phenotype that involved prion amyloid formation from the Ure2p proteinFootnote 5 (Wickner 1994). Wickner’s proposal was based on a set of experiments that involved overproduction of Ure2p, cytoplasmic transfer via cytoduction and reversible cycles of losing/regaining the [URE3] phenotypeFootnote 6 (Wickner 1994; Wickner et al. 1995, 1999; Masison et al. 1997; King et al. 1997; Edskes et al. 1999). In that original paper (Wickner 1994), Wickner additionally suggested that an amyloid-based mechanism, involving aggregation of the Sup35 protein,Footnote 7 would also be consistent with experimental knowledge concerning the [PSI+] yeast phenotype (Cox 1965; Tuite et al. 1983; Doel et al. 1994). The [PSI+] growth phenotype, originally discovered by Cox (1965), is known to result from an unusually high production of translational read-through eventsFootnote 8 (Didichenko et al. 1991; Stansfield et al. 1995; Serio et al. 1999). Following Wickner’s suggestion, a range of genetic (Patino et al. 1996) and biochemical investigations into [PSI+] (that even involved the introduction of an external amyloid created in vitro from recombinantly synthesized Sup35 protein into yeast to induce a stable [PSI+] phenotype) confirmed the amyloid prion basis of [PSI+] inheritance (Sparrer et al 2000). A third major amyloid prion system (in terms of applied research effort), termed [PIN+], was later discovered (Derkatch et al. 1997; Sondheimer and Lindquist 2000). Derived from the acronym for [PSI+] Inducibility, the [PIN+] phenotype was identified as an additional requirement for the production of [PSI+] amyloid (and the associated [PSI+] associated phenotypic traits) (Derkatch et al 2000; Sondheimer and Lindquist 2000). Using similar genetic and biochemical procedures the [PIN+] epigenetic trait was shown to be due to conversion of the Rnq1 protein into amyloid form (Patel and Liebman 2007). Since the original discovery that certain non-chromosomal epigenetic traits in yeast could be effected by an amyloid prion mechanism (Wickner 1994) a large number of additional yeast prions have been discovered (Wickner et al. 2015; Nakagawa et al. 2022) with the question as to whether yeast prions represent a disease or a potential benefit to yeast still being debated (Wickner et al. 2011; Halfmann et al. 2012; Wang et al. 2017).
In a manner that both precedes and runs parallel to, the discovery of the amyloid basis of the yeast epigenetic factors [URE3], [PSI+] and [PIN+], our general understanding of amyloid structure (Glenner et al. 1974; Lansbury et al. 1995; Adamcik et al. 2010; Jahn et al. 2010; Hall 2012; Eisenberg and Sawaya 2017; Meier et al. 2017; Iadanza et al. 2018), its mechanism of formation (Masel et al. 1999; Pallitto and Murphy 2001; Hall and Edskes 2004; Hall et al. 2015; Hirota et al. 2019) and its negative associations with the set of devastating amyloidosis diseases (Glenner and Wong 1984; Nowak et al. 1998; Merlini and Bellotti 2003; Hall and Edskes 2009, 2012; Martinez-Naharro et al. 2018; Weickenmeier et al. 2018; Fornari et al. 2019; Picken 2020) has continued apace. Since its original identification from patient biopsy/autopsy at the macroscopic (for an early history see Sipe and Cohen 2000) and molecular levels (Cohen and Calkins 1959; Bladen et al. 1966; Eanes and Glenner 1968; Prusiner et al. 1983; Glenner and Wong 1984) our present-day collective knowledge of the disastrous consequences arising from defects in the biological control systems regulating protein folding and amyloid production in vivo (Hardy and Higgins 1992; Labbadia and Morimoto 2015; Klaips et al. 2018) means that work directed at both delineating, and potentially controlling, the factors affecting these processes is, without hyperbola, of the utmost importance (Ohtsuka and Suzuki 2000; Aguzzi and Sigurdson 2004; Ringe and Petsko 2009; Wentink et al. 2019). Due to yeast possessing many of the same genes and proteins as those found in humans, the S. cerevisiae model system presents itself as an ideal vehicle for the interrogation of biological factors affecting amyloid growth within a biological setting. The ability to combine molecular biology and yeast genetic methods provides an experimenter with the ability to add (knock-in) or remove (knockout) genes, switch particular genes on or off (silence or enhance expression) and, in some cases, to subtly tune the expression levels of particular proteins (such as those associated with yeast chaperone and vacuoleFootnote 9 systems) to control the induction and loss of amyloids within an in vivo setting (Chernova et al. 2017; Son and Wickner 2022; Wickner et al. 2021). However, due to the highly complex and potentially non-linear nature of amyloid growth and transfer within a dividing and expanding set of cells, the results of such experiments crucially require simplifying (but not simple) mathematical models to aid with their interpretation. It is towards this goal that the present work is directed.
Procedures: how does the MIL-CELL computational tool work?
To simulate the growth and transmission of amyloid prion elements within and between a population of yeast cells a multiscale modelling approach called MIL-CELL has been developed (with this acronym standing for Monitoring Induction and Loss of prions in Cells). In our approach, the division and growth of yeast are described at the particle level whilst the behaviour of the amyloid prion elements is described microscopically using a set of chemical rate equations. In the next sections, we describe these two approaches in turn before then explaining how they are coupled together. The simulation format is designed to match with a particular type of yeast culture experiment in which cells are either grown and monitored via microfluidic/cell sorting assay (Scheper et al 1987; Huberts et al. 2013) or alternatively grown at one layer thickness under a coverslip (Cerulus et al. 2016; Mayhew et al. 2017; Zhao et al. 2018) thus reducing the problem to one of growth in either zero or two spatial dimensions.
Particle level model of yeast life cycle
Factors determining the growth and division of yeast within a colony
As per Fig. 2(top panel) we consider two distinct yeast states, a mature/mother state (M) and an immature/daughter state (D) (Hartwell and Unger 1977; Cerulus et al. 2016). These designated forms, respectively, undergo the following two transitions within the yeast life cycle (i) Mother yeast producing a daughter yeast (Eq. 1a), and (ii) Daughter cell growing into a mother yeast (Eq. 1b). Mature yeast are physically modelled as rectangular solids of aspect ratio 2 with actual dimensions of length, width and height, respectively, given by LM = 5 μm, WM = 2.5 μm and HM = 2.5 μm (Nagel 1946; Hartwell and Unger 1977; Cerulus et al. 2016). Immature yeast is represented as spheres with a radius, RD, equal to half the width of the mature cell i.e. RD = 1.25 μm. At time zero, a single mature yeast cell is placed on a central area of a plate defined by a sector wedge, beyond the bounds of which the yeast is unable to grow. Progression through the yeast life-cycle is modelled as a series of transitions, with each advance governed by a pairing of a minimum time delay, δ, and a transition time, τ specified in relation to a time, t, recorded from the starting point of its previous transition (Eq. 1).
Successful passage through these various life transitions (here generalized as I → J) is governed by a transition probability P(I → J) which is itself a function of time, t, and local yeast density, ρlocal. To formulate the transition probability into algorithmic form we first decompose it into the product of two limiting probabilities (Eq. 2a). The first limiting case involves the transition of an isolated yeast (zero local density) at some finite time t, defined in relation to the limiting minimum delay δI→J. This transition probability is determined in a stochastic fashion on the basis of a first-order process calculated using the characteristic time constant (Eq. 2b) (Hartwell and Unger 1977; Lord and Wheals 1980). The second limiting case considers the transition at infinite timeFootnote 10 but at non-zero local yeast density such that transition success is wholly determined by the ability of a growing yeast bud, or daughter cell, to overcome any virtual pressure generated by local yeast occupancy, due to either a preference for cohesion between yeast in a colony (so-called cell to cell contacts) or the formation of anchor points between the yeast and the plateFootnote 11 (Roy et al. 1991; Bony et al 1997). To model this virtual pressure aspect associated with yeast growth within a colony, all yeast, obstructing either the point of intended daughter formation or daughter enlargement, which could impede such growth, are first identified (Fig. 2—middle panel). Knowledge of the number and placement of these surrounding yeast is then used to calculate a Metropolis-like weighted selection term based on a dimensionlessFootnote 12 energy, ΔΕ*, that factors in the requirement to push any (and all) obstructing yeast away from the point of daughter formation/enlargement (Eq. 2c) (Leach 2001). The energy term appearing in Eq. 2c is calculated from the following parameters; ε—the reduced energy required to push one yeast segment a minimal distance 2RD and min[N(┴), N(┬)]—the smallest value from the set of the total number of obstructive yeast segments that have to be moved in one of the two opposing Cartesian directions (Eq. 2d).Footnote 13
For the M → D transition the bud may appear on any one of six positions of the yeast faces that are perpendicular to the growth surface (Fig. 2—middle panel). For the D → M transition, one of four potential positions (located a distance 2RD from the center of the grown bud and aligned parallel to the xy axes) is selected (Fig. 2—middle panel). For all putative growth transitions, if P(I → J, ρlocal = 0, t) = 1, then all sites are tried via random selection without replacement until either P(I → J, ρlocal, t → ∞) = 1 or no further selections are available, in which case P(I → J, ρlocal, t → ∞) = 0 and the total probability in Eq. 2a is set to zero i.e. P(I → J, ρlocal, t) = 0.
Accounting for variability in yeast strain and individual cell characteristics
MIL-CELL simulations consider the growth of yeast belonging to a single strain type (with strain defined by a degree of isogenic character/and morphology) (Louis 2016). At time zero, the yeast on the plate, N(t = 0), is considered first generation, G = 1, and assigned a unique index, H = 1, associated with its time of appearance on the plate. For all subsequent divisions, each indexed cell is assigned both a generation index, G = 2, 3, …, a unique index H such that H ∈ [1, 2, …, N(t)] and a specific cell lineage (written as a concatenated list of the particular indices of cells involved in the division chain). Together with the particular transitive state of the yeast (D, M) this information can be used to partially define the state and history of each yeast on the plate.
Despite their isogenic nature, individual members of the same yeast strain will exhibit variation in their growth and division patterns, due to differences in internal constitution (e.g. mutations, stochastic separation of cytosolic components during division) and the external micro-environment (e.g. temperature, plate medium, surrounding cell density etc.) (Hartwell and Unger 1977; Snijder and Pelkman 2011; Cerulus et al. 2016; Mayhew et al. 2017). To include these variations within the model the transitive time constants are modified using a number randomly selected from a normal distribution A{Aav(G), σA(G)} characterized by a mean, Aav, and a standard deviation, σA, which are both in turn set as functions of the yeast generation index. At each stage of growth the individual yeast cell’s transition time constant is allowed to vary (Eq. 3) (Fig. 2—lower panel).
If Aav(G) equals zero and \(\sigma _{\text{A}}\text{(}{\text{G}}\text{)}\text{ } = \sigma_ {\text{A}}\text{(}{0}\text{)}\) throughout the course of yeast colony formation then Eq. 3 ensures limited variability in the individual time constants around their mean value τi→j(0). However as different strains will undergo different extents of evolutionary drift (via genetic and epigenetic routes) through multiple rounds of cell division, the potential for changes occurring in both the mean and variance parameters is extant (Cerulus et al. 2016; Mayhew et al. 2017). To include such variational characteristics within the model both the average and standard deviation, defining the normal distribution A, are allowed to vary through multiple rounds of cell division (Fig. 2—lower panel) as per a recursive formula (Eq. 4) which employs random selection from a second set of normally distributed numbers, B(0, σB), defined by a zero mean and a standard deviation, σB.
Inescapable tendencies towards greater entropy hardwired within the recursive identity of Eq. 4 will lead to a broadening of the population-level distribution of Aav and σA (as a function of generation time (G))—thereby inducing diversity within the reproduction kinetics of the yeast population.
Description of cell age in a chronological and a replicative sense
There are two definitions of age relevant to a discussion of cell growth. The first is chronological age, which describes the actual time for which the cell has been alive (Bitterman et al. 2003; Longo et al. 2012). Considerations of chronological age can be important when the cell is exposed to any phenomenon which exhibits a time-accumulated effect [e.g. time cell is exposed to ultra violet light or chemical mutagen (Longo and Fabrizio 2011; Khokhlov 2016)]. The second relevant measure of age is the replicative age, which describes how many times the cell has undergone the cell division process to produce a daughter cell (Barton 1950; Steinkraus et al. 2008). There are a number of interesting features about both of these measures of cell aging with regard to epigenetic phenomena. For instance, one theory of cell division termed the maternal protective effect, is based on the observation of preferential retainment of damaged cellular components by the mother cell to allow the growing daughter cell to get off to the best possible start in life (Kennedy et al. 1994; Steinkraus et al. 2008). Within MIL-CELL both linear and replicative ages are recorded for each cell in the virtual culture. Allowance can be made for the occurrence of cell death after set linear and replicative ages at which stage the yeast disappears from the culture plate. In the case where amyloid represents a disease of yeast, both the growth parameters and the age at which the yeast cell dies, can be parameterized in response to amyloid load (Wickner et al. 2011; Douglas et al. 2008).
Mesoscopic assignment index: observable properties of yeast at the individual cell level
Taken all together Eqs. 1–4 allow for the definition of an information set Y with each table row defining a particular yeast’s state (at the particle level of consideration) using the indexing scheme shown (Eq. 5) (with the additional terms indicated by … to be added in a subsequent section).
Up to this point, we have described how to specify the physical location and division cycle particulars of each yeast cell within a growing colony. However, we have not yet specified any mechanism for describing information on the state of the amyloid prions existing within each yeast cell. To remedy this deficiency, in the next sections we describe a chemical rate model of amyloid prion growth and then explain how to integrate this modelling framework into the particle-level description of the yeast life cycle to generate a true multi-scale model that is able to inform on the amyloid prion population within the yeast during its growth and colony formation on a plate.
Microscopic description of amyloid prion chemical processes
Chemical rate equations describing the behaviour of yeast prions within each yeast cell
Conforming to the original discoveries of Wickner, we assume that the fundamental basis of the transmissible prion unit in yeast is protein amyloid (Wickner 1994; King and Diaz-Avalos 2004; Brachmann et al. 2005). In keeping with this point, here we describe methods for simulating the nucleation and growth of amyloid from its monomeric protein precursor based on the numerical integration of a set of chemical rate equations (defined by such polymer nucleated/growth considerations) (Hall and Edskes 2012; Hirota et al. 2019; Hall 2020a). In what follows, we consider two general sets of amyloid growth equations that are capable of producing three distinctive prion kinetic behaviors observed in yeast described as ‘dissolution/munching’ (~ increased rate of endwise depolymerization), ‘inhibition of fiber breakage’ (reduced rate of internal fiber breakage) and ‘clumping’ (self-association of amyloid fibers) with this latter process associated with asymmetric segregation upon cellular division (Zhao et al. 2018) (Fig. 3—upper panel). We describe in detail the elementary steps both common and particular to these three general behaviors before providing the relevant equation sets.
Protein production The formation and breakdown of protein monomer, M, from (and to) its constituent amino acids, is considered to be, respectively, regulated by first-order rate constants, fM and bM. The concentration of amino acids available for monomer production is itself parameterized in terms of the total mass concentration of amyloid, its basal set-point concentration (CAA)basal at zero amyloid concentration and two empirical parameters, Ω and Ψ (Eq. 6). This parameterization accounts for the fact that amyloid is believed harmful to the cell beyond a certain concentration (Wickner et al. 2011; Douglas et al. 2008; McGlinchey et al. 2011) therefore making its own production self-limiting at some extent of amyloid production.Footnote 14 We interpret this self-limiting aspect as a general decrease in metabolic function modelled as a decrease in the available pool of cell resources.Footnote 15
Amyloid nucleation The initial amyloid nucleation process is considered to occur via an association event of molecularity n, governed by an nth-orderFootnote 16 association rate constant, fN. Nucleus dissociation is considered to be governed by a first-order dissociation rate constant, bN.
Amyloid growth via monomer addition/loss Amyloid growth and dissociation is specified to occur in a simple manner via monomer addition to a single fibril end, governed by the second-order rate constant fG, and monomer dissociation from either of the fibril ends,Footnote 17 governed by a first-order rate constant bG.
Amyloid growth (linear fiber addition/breakage) Amyloid fiber growth and breakage may additionally occur via fiber end-to-end joining (Binger et al. 2008), regulated by a second-order association rate constant, fA1, and internal breakage, governed by a first order site-breakage rate constant, bA1.
Amyloid growth (lateral fiber addition/dissociation) Amyloid ‘clumping’ may also occur by fiber lateral association with the forward reaction governed by a second order association rate constant, fA2, and the reverse reaction governed by the first order rate constant, bA2. The fiber clump is considered to be able to undergo growth via monomer addition to the two available ends (unidirectional growth) with this growth regulated by the second-order rate constant fG. Due to the potential additional stabilization of the fibers due to their lateral alignment, the clumped fibers are considered not to be able to undergo either monomer dissociation or fiber breakage in the stabilized clumped state.
Species partition The monomer and amyloid components may migrate between mother and nascent daughter cellsFootnote 18 via differential partition during the budding phase resulting in daughter cell formation (Fig. 3—lower panel). As such, each different chemical component was assigned two directional partition constants, (ki)αβ and (ki)βα, (units of s−1) respectively referring to the migration of component i from the mother (α phase) to the daughter (β phase) cell, and from the daughter to the mother cell. Due to the unequal volumes of the mother and growing bud a volume correction is applied to components entering and leaving the compartment with the larger volume (mother cell).
Towards formulating simplified mathematical representations of these events described in terms of their species concentrations, Ci and mechanistic [fi, bi] and partition, [(ki)αβ, (ki)βα] rate constants governing each set of forward and reverse elementary steps, we provide compartment specific (Q = α (mother) or β (daughter)), definitions for the amyloid number, {CA1}Q and mass concentrations, {CMA1}Q for a single filament, along with the equivalent concentration definitions for, the clumped (paired) filaments, {CA2}Q and {CMA2}Q (Eqs. 7a–7d).
Using the species defined in Eq. 7 along with a number of simplifying assumptions (which will be outlined below) we can write sets of rate equations that describe amyloid growth under relevant different limiting conditions (Zhao et al. 2018; Greene et al. 2020).
Kinetic model capable of fiber scission and longitudinal/lateral fiber self-association (breakage and clumping)
A set of inter-related differential equations capable of describing amyloid fiber breakage, clumping and partition between the mother and daughter (with the partition term to be defined subsequently) can be derived upon making the following assumptions (i) that the nucleus size, n, is 2; (ii) the nucleus dissociation rate, bN, is equal to the dissociation rate of monomer from the fibril, bG; (iii) there is no positional dependence to the intrinsic breakage rate i.e. bA1 = bG at all fracture points. These equations describe the phase-specific rate of change in the concentration of monomer, (CM)Q (Eq. 8a), the number concentration of single filament (CA1)Q (Eq. 8b), the number concentration of paired filaments (CA2)Q (Eq. 8c), the mass concentration of single filaments (CMA1)Q (Eq. 8d) and the mass concentration of paired filaments (CMA2)Q (Eq. 8e) with the average size of the single and paired filaments (Eq. 8f and 8g).
For the case of no fiber breakage {bN = bG = bA1 = 0 s−1} and no fiber joining or clumping {fA1 = fA2 = 0 M−1 s−1} the chemical regime conforms to models of irreversible nucleated growth first pioneered by Oosawa and others (Oosawa and Asakura 1975). For the case where breakage is finite i.e. {bN = bG = bA1 > 0 s−1} without joining or clumping {fA1 = fA2 = 0 M−1 s−1} the chemical regime conforms to a standard consideration of amyloid kinetics (Hall and Edskes 2009). When the joining and clumping rates take on a finite value {fA1 > 0 M−1 s−1; fA2 > 0 M−1 s−1} the fiber number concentration will be modified reflecting this fiber self-association (Zhao et al. 2016; Hirota et al. 2019).
Kinetic model capable of position-dependent breakage (endwise dissolution ‘munching’)
To simulate preferential endwise depolymerization of amyloid filaments [the so-called endwise dissolution or ‘munching’ case (Zhao et al. 2018)] a previously developed mathematical model, able to account for position-dependent differences in fiber fracture rate i.e. bG ≠ bA1, was utilized (Hall 2020a). Limited to the consideration of single filament growth this model is capable of describing the time dependence of monomer formation (Eq. 9a), the number concentration of fibrils (Eq. 9b) and the mass concentration of fibrils (Eq. 9c) under the following assumptions (i) that the nucleus size, n, is 2; (ii) the nucleus dissociation rate, bN, is equal to the dissociation rate of monomer from the fibril, bG; (iii) the phase-dependent concentration of the nucleus (C2)Q is estimated by assuming an exponential shape of the fibril distribution (Eq. 9e) for which the decay constant is calculated on the basis of knowledge of the average polymer degree (Eq. 9d, f) (Hall 2020a).
With the basic form of the kinetic equations for amyloid growth occurring in a fixed volume we now describe the functionalization of the partition term.
Partition of chemical components between the dividing mother and the daughter cell
Partition refers to the migration of the specified monomer and amyloid components between the mother and daughter cells during cell division (Marchante et al. 2017; Zhao et al. 2018; Heydari et al. 2022; Greene et al. 2020). The partition terms are shown in equation sets 8 and 9 are necessarily different for each component and are also biased by a volume factor dependent on the volume compartment Q being discussed (either α (cell) or β (daughter) cell). The partition equation, written in terms of generalized parameters, is given (Eq. 10)Footnote 19
With suitable initial values, equation sets 8 and 9 (with the partition terms described—Eq. 10) are sufficient to describe characteristic growth patterns within yeast of unchanging physical dimensions (stationary phases) or alternatively a ‘frozen’ state of a dividing yeast. A multi-panel display (Fig. 4) describes the changes in the time-dependent formation of monomer and amyloid as the kinetic parameters are systematically varied at fixed values of the other parameters in an unchanging solution vessel (e.g. as for a chemical beaker). However, in the form shown, equation sets 8 and 9 cannot account for the kinetics of amyloid in a cell compartment undergoing volume change with time. To model this feature we need to recast the set of ordinary differential equations described by equation sets 8 and 9 (in which the only independent variable is time), into a set of partial differential equations written in terms of the independent variables of time and volume. We begin by describing the total differential for the concentration of species k in terms of change in time and volume (Eq. 11a). Approximating the derivative as a difference equation yields a functional form for the derivative (Eq. 11b).
Having described means for modelling the time evolution of the different amyloid components within each yeast cellular space we may supplement the yeast population information set Y (described in Eq. 5) with additional time-dependent chemical information, with the specific terms indicated (Eq. 12).
In Eqs. 1–12 we have described the yeast at the particle and the microscopic levels. In the next section, we describe how these different levels of simulations are combined.
Coupling of the mesoscopic and microscopic simulations
Algorithmic control of multiscale processes
Each life cycle-associated cell volume change is considered to occur over the coarse time interval, Δt′, used in the particle model, with this volume increment broken into smaller time increments Δt determined by the number of time steps, Nsteps, used in the numerical integration routine for solving the amyloid kinetics (such that Δt = Δt′/Nsteps. The particle model is updated at a regular interval Δt′. When the t + Δt′ time point reached, for each cell we carry out the following,
-
(i)
Apply a Metropolis-like test to determine the success or otherwise of the I → J transition (over Δt′).
-
(ii)
Solve the appropriate kinetic rate equations for amyloid aggregation within each yeast during the t → t + Δt′ period during which the I → J transition did (or did not) take place with either,
-
(a)
Eqs. 8 and 9 used for those periods of growth featuring fixed geometry, or
-
(b)
Eq. 11 for periods of growth with changing geometry.
-
(a)
-
(iii)
For the case of a mother-daughter pairing the differential partition relation is used to account for uneven sharing of cellular contents at the time of septum closure (Eq. 10).
-
(iv)
Next time advancement step in particle model (next Δt′).
The differential equations are shown in equation sets 8–11 are evaluated using a modified-midpoint method in the numerical integration procedure (Press et al. 2007). At the conclusion of each coarse interval Δt′ the end values are then used as the initial values in the next round of computation.
Colour-based inference of the presence or absence of the yeast prion
In principle, yeast can display an observable phenotype that is caused by either the presence of prion [i.e. via a fluorescent screen in which the yeast are subsequently fixed and stained with a dye that is active upon encounter with amyloid (Summers and Cyr 2011) or the amyloid-forming protein is a fusion construct containing a fluorescent tag (Zhao et al. 2018)] or the absence of the monomer [in which the enzymatic activity is monitored (Alberti et al. 2010)]. A number of biochemical assays can be applied/engineered within the yeast to make the detection of the prion easy to carry out at the macroscopic level. Figure 5 describes the details of the assay for the identifying yeast cells containing either the [PSI+] or [URE3] prion, respectively, made from the Sup35 and Ure2 proteins (Schlumpberger et al. 2001; Alberti et al. 2010; Brachmann et al. 2006) (Fig. 5a). Broadly speaking, within an engineered yeast strain containing a premature stop codon within the ADE1 gene, the presence of the free monomer protein within the cytosol prevents expression of the Ade1p protein (coded by the ADE1 gene) which catalyses enzymatic breakdown of a coloured intermediate of the adenine biosynthetic pathway thereby causing the yeast cells to become red (also requiring that the growth media be supplemented with adenine). In the absence of free monomer (either Sup35 or Ure2p), such as when all monomer is in the inactive amyloid form, the dye-converting enzyme is made and the yeast cells turn white (also meaning that the prion-containing yeast can grow on adenine free media).
To quantitatively model the colour assay we have utilized a simple power dependence of the fractional level of change in monomer between a minimum and maximum threshold limits (Eq. 13). In signal processing such an equation is termed the gamma transformation with values of γ = 1 denoting a linear dependence, γ > 1 denoting a ‘cooperative’ non-linear dependence and values of γ < 1 denoting an ‘anti-cooperative’ non-linear dependence (Poynton 1998). A unique mapping is assigned in colour space by relating the fractional transition in monomer to the fractional transition in white to red colour space based on an 8-byte RGB representation with white denoted as [255, 255, 255] and red as [255, 0, 0] (Fig. 5b).
The colour transform described in Eq. 13 allows for a simple and direct means for simulating the amyloid status of any particular yeast via ‘visual’ inspection of the colony (Brachmann et al. 2006; Alberti et al. 2010). In what follows we will utilize both the particle level colour assessment and the microscopic chemical description to examine the epigenetic consequences associated with different parameter regimes of yeast and amyloid growth.
Results: what can the MIL-CELL computational tool do?
Having explained the physical basis of the MIL-CELL model we now describe some of the types of virtual experiments and analysis results achievable with this software tool. Although not limited to the following we describe four types of potentially interesting in silico experiment that can be carried out within MIL-CELL that conform to (i) Colony interrogation, (ii) Confluence analysis, (iii) Lineage and fate mapping, and (iv) Yeast curing experiments.
Colony interrogation
After specifying the yeast properties and initial conditions yeast cells are grown virtually, allowing for the spread of amyloid prions within them. A useful aspect of the simulation is that it provides near complete knowledge of the behaviour of the system in a manner that is frequently not achievable even with the most carefully designed experiment. Taking advantage of this aspect of the MIL-CELL computational tool we have implemented a relational database that allows the user to investigate the properties of the yeast colony (e.g. number of cells of a particular generation, their inherited variability, time of birth, time as daughter and time as mother) and all aspects relating to their cell contents (e.g. concentration and distributive state of the monomer and various amyloid forms) (Fig. 6).
Confluence analysis
Depending on the degree of interaction of the growing cells with the support medium and/or other nearby cells there will be some difference in preference for growth occurring external to the colony (i.e. at the edges) vs. internally (thereby requiring displacement of surrounding cells). By varying the confluence parameter ε (shown in Eq. 2d) we can alter the growth patterns of the yeast to either respect the local confluence conditionFootnote 20 or not respect local confluence and thereby grow in a less controlled fashion without effect from their surrounding neighbouring cells (Verstrepen and Klis 2006) (Fig. 7).
Cell lineage and fate mapping
When conducting epigenetic linkage analysis a defined history of cell lineage is crucial for understanding how the epigenetic properties of a particular cell were determined by its immediate ancestors. In both the analysis of simple cell culture experiments and more complex pathways of growth and division in multicellular organisms such a history is known as a cell lineage map (Woodworth et al. 2017). Within the MIL-CELL program a particular cell within the two-dimensional cell culture experiment can be interrogated by a button click to identify the unique index k (Eq. 5) assigned to it in order of its birth (Fig. 8a). Upon selection of the ‘Complete Lineage’ option history of the chosen cell (that traces back each mother–daughter pairing to the original cell (k = 1)) will be shown in a new window (Fig. 8b). This graph can be used to identify the time of birth of each ancestor and the time course of the epigenetic components (chemical contents in terms of monomer, amyloid protofilaments and clumped amyloid fibers) as they are transferred through the lineage. A second type of forward-looking analytical tool, known as a cell fate map is also available within MIL-CELL (Fig. 8c). Based on the description of all the offspring produced by a particular cell, the forward-looking fate map can reveal differences in inherited epigenetic components between sibling cells due to birth-order effects (Cerulus et al. 2016; Mayhew et al. 2017).
Yeast curing experiments
A type of multi-generation in yeast dilution experiment, known as yeast curing, was used to establish both the cytosolic location and the amyloid prion nature of the epigenetic phenomenon (Eaglestone et al. 2000; Wegrzyn et al. 2001; Byrne et al. 2009; Greene et al. 2020). In this experiment, yeast are allowed to divide a number of times, with each generation tested for the presence of the epigenetic trait. The general hypothesis of the yeast curing experiment is that with each division cycle the contents of the cytosol are shared between an increased volume of cytoplasm (that of both the mother and newly formed daughter cells) and therefore undergo dilution (Eaglestone et al. 2000; Cole et al. 2004; Byrne et al. 2007, 2009). In practice, this experiment can be carried out either by growing several generations in solution with intermittent analysis via plating or via direct analysis of the yeast phenotype as it divides on the plate (known as a colony splitting/sectoring experiment) (Sharma and Liebman 2012).Footnote 21 The MIL-CELL program can simulate both forms of the yeast curing experiment with three examples of complete to partial curing generated by different mechanisms shown in Fig. 9a–c. A different manner for visualizing the yeast curing experiment involves plotting the fraction of cells not exhibiting the epigenetic phenotype against their generation number (Eaglestone et al. 2000; Sharma and Liebman 2012). To facilitate this representation MIL-CELL allows the user to specify the nature of the epigenetic marker (e.g. concentration of monomer or alternatively the concentration or number of prions) and to decide on the value of the binary classifier (i.e. what value demarcates the binary evaluation ([PSI+] or [psi −] of the epigenetic characteristic) (Fig. 10). Different specification of the type and value of this binary classifier can drastically affect the nature of the yeast curing curve.
The four just-described examples provide some insight into the potential usefulness of the MIL-CELL program for modelling various types of yeast prion experiments. In the next section, we discuss how MIL-CELL compares with other models of yeast prion growth and transmission and how it may be applied more generally to other biological and disease phenomenon.
Discussion
The starting intention of the present work was to describe how the MIL-CELL software could be used to model epigenetic effects mediated by the transmission of amyloid prions within yeast. However, due to the generality of the MIL-CELL modelling approach it has not escaped the author's notice that MIL-CELL may have a, not insignificant, potential to provide insight into a diverse array of general phenomena associated with eukaryotic cell growth and asymmetric division of cell contents in a manner that lies beyond the present discussion just associated with yeast prions. To place this work in both specific and wider contexts we have approached this discussion in the following manner. We first discuss MIL-CELL features in relation to the large numbers of models of yeast growth and division up to, and including, very recent models which feature prion growth and transfer. After presenting the strengths and weaknesses of the MIL-CELL program in relation to those other approaches we then place our focus on the biology of the processes modelled and compare our reduced description to the current best understanding of how these complex processes occur in actuality. Finally, we discuss the potential of MIL-CELL in a wider context, by speculating on how it might be used to provide insight into a number of basic biological phenomena (such as cellular differentiation and cellular variability within a population) as well as cellular processes associated with disease (such as amyloidosis, cancer and mitochondrial dysfunction).
MIL-CELL as a tool for modelling yeast growth/division and prion growth/transmission
To the best of our knowledge, MIL-CELL is the only model in existence that explicitly describes both (i) the spatial relationship between each yeast as they grow and divide in culture, and (ii) the time-dependent chemical kinetics of amyloid prion growth and transmission within and between yeast. To achieve this feat MIL-CELL employs a multi-scale approach, meaning that it basically comprises two models in one, and as such we discuss these two different aspects in turn.
Particle model of yeast growth Aside from being the principal model system used by cell biologists for elucidation of the genetic and biochemical factors responsible for regulating the eukaryotic cell cycle (Mitchison 1971; Hartwell 1974; Forsburg and Nurse 1991). S. cerevisiae has also played a key role as the experimental focus of biophysical cell modelling studies due to its reproducible growth patterns and ease of assignment of distinct growth states under both light and scanning electron microscopesFootnote 22 (Hartwell and Unger 1977; Chant and Pringle 1995; Snijder and Pelkmans 2011; Cerulus et al. 2016; Mayhew et al. 2017). An important distinction to make at the outset of any discussion of cell modelling is that yeast can either be cultured in a liquid growth medium or on a solid growth medium (such as an agar plate) (Andrews et al. 2016). In a well-stirred liquid-growth medium the yeast tend to dissociate upon division, hence removing any associated positional considerations (Hartwell and Unger 1977; Lord and Wheals 1980) allowing them to grow unhindered until either resources become limiting or growth is slowed due to the release of quorum sensing factors at high yeast densities (Andrews et al. 2016). Due to this simplifying feature, a lot of the early quantitative studies of yeast growth were carried out in liquid culture. Adopting the same descriptive transitive states of cell growth and division as shown in Fig. 2, Hartwell and Unger used such experimental data to parameterize yeast growth rate constants under numerous growth conditions. Their quantitative modelling approach, restricted to the time domain and based on the assumption of exponential growth, yielded a number of important analytical forms relating differences in daughter and mother cell doubling times to overall growth rate (Hartwell and Unger 1977; Lord and Wheals 1980). Recent quantitative studies of yeast growth have focused more carefully on these time constants by characterizing the dependencies of observable physical markers of cell growth on the different states of the division cycle (Soifer et al. 2016; Mayhew et al. 2017) whilst also examining the effect of noise and lineage on the stability of these time constants within a growing population (Cerulus et al. 2016). MIL-CELL has attempted to implement both the older classical viewpoints and these newer findings by combining routines involving the stochastic sampling of time constants (Eqs. 1 and 2b) with allowance for variability within and between yeasts according to their generation and lineage (Eqs. 3 and 4). For the sake of tractability, some observed mechanistic features of yeast growth have been sacrificed, such as the slow continual growth of mother cells to form slightly larger mother cells (Vanoni et al. 1983). When yeast is grown on a solid culture (or even when grown in an unstirred solution) density and position effects will start to become a non-negligible aspect in the determination of yeast proliferation (Shah et al. 2007; Rivas et al. 2014). The particle level description in MIL-CELL simulates yeast growth and division in two-dimensional culture as would be the case for yeast grown under restrictive conditions (Zhao et al. 2018; Huberts et al. 2013). If growth is not restricted by the use of a distance-regulated coverslip arrangement, yeast will tend to form three-dimensional colonies with observation of the underlying cells occluded by their placement within the colony (Vulin et al. 2014; Ruusuvuori et al. 2014). Whilst the current approach could be quite simply extended to three-dimensions the primaryFootnote 23 reason for limiting it to two-dimensions is due to this inherent observational barrier associated with three-dimensional culture. The approach used in MIL-CELL for factoring in density effects is based on stochastic sampling against a pseudo-energy function (depicting the effort required to ‘push’ surrounding cells out of the way in order for internal cells to themselves grow or alternatively give birth to a new daughter cell) (Eqs. 2c and 2d). As the MIL-CELL yeast growth model is based on a set of rules it has characteristics of agent-based models first employed by Eden in the description of cell colony growth (Eden 1960). Similar agent-based modeling approaches have been used to describe fungal growth (Laszlo and Silman 1993), confluent growth (Lee et al. 1995), bacterial growth (Kreft et al. 1998), tumor biology (Drasdo and Höhme 2005) and nutrient limitation in two-dimensional yeast colony formation (Banwarth-Kuhn et al. 2020). Whilst a defect of the MIL-CELL model is the requirement for a fixed geometrical dependence (involving modelling mother cells as rectangular solids and daughter cells as spheres) to the best of the author’s knowledge the approach specified in this paper is the only one capable of transitioning from locally confluent to non-confluent growth via specification of a single parameter (ε in Eq. 2d—see Fig. 7). Without this ability growth will nearly always occur at the colony edge. Finally, by implementing a consistent color screen capable of accommodating nonlinear variation, the model has the potential for provision of insight into questions relating to weak vs. strong phenotypes (Eq. 13, Fig. 5—see Figs. 9 and 10 for examples) (Sharma and Liebman 2012).
Models of prion growth and transfer From the time of the initial association of prions with diseases such as Kuru and Scrapie (Poser 2002a, b; Liberski 2012) there has been a great effort to quantitatively model both prion chemical and epidemiological dynamics (Nowak et al. 1998). The first mathematical insight into polymer-based prion behavior was by Griffith (1967). During a period of scientific uncertainty as to the exact biological nature of prions (Gajdusek 1977; Prusiner 1982; Weissmann 1991), the required chemical mechanisms and mathematical forms of various types of protein-based prion models were debated (Come et al. 1993; Eigen 1996; Nowak et al. 1998). Borrowing heavily from quantitative models applied to the polymerization of proteins such as hemoglobin, actin and tubulin polymerization (Oosawa and Kasai 1962; Wegner and Engel 1975; Hofrichter et al. 1974; Oosawa and Asakura 1975; Bishop and Ferrone 1984; Flyvbjerg et al. 1996; Hall 2003; Hall and Minton 2002, 2004) early kinetic models of amyloid prion biology attempted to describe the spontaneous formation and differential transmission between host and recipient in terms of equivalent one-dimensional crystal growth and crystal seeding experiments (Nowak et al. 1998; Masel et al. 1999; Pallitto and Murphy 2001; Craft et al. 2002; Hall and Edskes 2004, 2009, 2012; Matthäus 2006). With specific regard to the transmission of amyloid prions in yeast, three general types of approaches have been attempted, (i) probabilistic models based on stochastic parameters (Eaglestone et al. 2000; Cole et al. 2004; Byrne et al. 2009), (ii) kinetic models based on impulsive differential equations (Lemarre et al. 2020) and (iii) models based on spatial continuum dynamics of aggregate growth and movement (Heydari et al. 2022).
To more clearly contrast the relative merits of these three alternative types of modelling approaches for describing prion growth in yeast against the approach adopted in the current work I first point out some of the distinctive points of the methods implemented within MIL-CELL for modelling amyloid growth and transfer. A strong point of the MIL-CELL method is the numerical approach employed for coupling the ordinary differential equation sets with the necessary partial differential equation forms required under conditions of changing volume and time (Eq. 11). The importance of including such concepts can be gathered from noting the predicted decrease in amyloid concentration during periods of rapid daughter cell growth with concomitant recovery of monomer concentration (due to it not being sequestered into amyloid—see Fig. 9 and 10). This numerical approach also has the added benefit of allowing for the direct usage of amyloid rate models determined and parameterized from quantitative experimental observations made under the typical constant volume in vitro conditions such as would be achieved using a microplate or cuvette system (e.g. Xue et al. 2008; Hall et al. 2016). The kinetic models implemented in MIL-CELL are cast in terms of experimentally observed mechanisms previously demonstrated to have relevance to biology (e.g. variable internal versus endwise amyloid breakage relationships (Hall 2020a), various nucleation and growth relationships (Nowak et al. 1998; Pallitto and Murphy 2001; Hall and Edskes 2004, 2009, 2012; Hall and Hirota 2009; Hirota et al. 2019) and various higher-order (end-to-end or lateral joining) amyloid association (Zhao et al. 2016). Another important and distinctive feature of the current work is the specifiable component partition rate between mother and daughter cells during cell division (Eq. 10). Through inclusion of this term I have highlighted the need for its subsequent experimental or computational determination and/or further functionalization in relation to its size or yeast properties. Consideration of this point will likely prove key in understanding the generation time versus physical time disparities associated with the analysis of yeast prion curing curves (Marchante et al. 2017; Heydari et al. 2022).
In relation to the above description of MIL-CELL we note that the formulation of amyloid growth and transmission in the probabilistic models employed by the Cox, Morgan and Tuite collective (Eaglestone et al. 2000; Cole et al. 2004; Byrne et al. 2009) rely on a series of discontinuous decision-based stochastic jumps between yeast generations. Whilst this approach has an, in principle, capability for monitoring the spread of the yeast prions with yeast position, in practice this was not employed by the authorsFootnote 24 (Byrne et al. 2009). An advantage of the probabilistic approach is its ready usage in fitting data gathered from experimental curing curves (Byrne et al. 2009) (e.g. see Fig. 10), however, without any continuous physical governance of chemical behavior this type of model is very much limited by the veracity of the assumptions governing the component behavior and transfer between different yeast generations. A different approach for describing amyloid growth and transmission in yeast was based on the use of sets of impulsive ordinary differential equations (LeMarre et al. 2020). Although the modelling approach was decoupled from the physical placement of the yeast on the plate the authors used this method to demonstrate the existence of a bistable regime corresponding to the possible coexistence of [PSI+] and [psi −] within the same colony—the so-called colony sectoring experiment (Sharma and Liebman 2012; LeMarre et al. 2020). Some negative aspects of the method adopted by LeMarre et al. include its slightly unphysical aggregation mechanism, its reliance on a fixed cell division time and the use of set rules for partition of cellular contents made on the basis of mother and daughter volumes alone. One further weak point is that the formulation of the differential equation set seems unsuited to conditions involving both changes in volume and time. The final alternative approach which we discuss here is the use of spatial continuum dynamics for describing aggregate growth and transfer (Heydari et al. 2022). Based on realistic descriptions of yeast geometry and internal components this approach is potentially superior (although much more computationally intensive) to the one described in the present work, however, at present it has only been applied to the description of a protein monomer–dimer interaction within a single dividing cell (Heydari et al. 2022). Also noted by the authors, the continuum dynamics approach potentially breaks down at low absolute molecular number, potentially necessitating a switch to a discrete particle simulation method such as the Brownian dynamics approach (Hall et al. 2006; Auer et al. 2008; Hall and Hoshino 2010).
To summarize this section, we note that MIL-CELL simulations are made on a per-cell basis, the simulated information in each cell is given in terms of realisable experimental information (e.g. concentration of protein monomer and size and concentration of amyloid polymer) and the spatial and inheritance relationships of all yeast cells are both defined and interrogable. In concert, these capabilities provide MIL-CELL with unrivalled power for realistic simulation of, and comparison with, prion transmission experiments in yeast.
Biochemical complexity of the epigenetic phenomenon
The starting motivation for the MIL-CELL project was to provide a means for modelling the nonlinear dynamics of prion-based epigenetic inheritance in yeast. The term ‘molecular epigenetics’ is frequently understood as referring to the differential transfer of an active biochemical factor between mother and daughter cells such that the biochemical factor is capable of influencing recorded expression profiles in a manner not necessarily consistent with the genetic sequence information contained within the chromosomal DNA (Waddington 1942; Manjrekar 2017). Two early realizations of such an ‘active biochemical factor’ for affecting changes in gene expression included (i) chromosome-specific DNA methylation (Razin and Riggs 1980; Weissbach 2013), and (ii) post-translational modification of the histone proteins in chromatin (Burggren 2016; Manjrekar 2017; O’Kane and Hyland 2019a). In normal mitotic cell division, the distribution of genetical material is effectively digital in nature, with one copy retained by the mother and one copy transferred to the daughter. However, if an epigenetic factor is not evenly distributed there will be an unequal transmission of genetic material between mother and daughter cells which can lead to differences between them (Weissbach 2013; O’Kane and Hyland 2019a). Similarly, in the case of meiotic cellular division with subsequent sexual reproduction, such unequal distribution of epigenetic factors amongst the gametes can significantly affect the likelihood of observing normal ‘expected’ Mendelian phenotypes on the basis of genotype (Kota and Feil 2010). Another important, yet different, area of epigenetics arises from the maternal effect—a catch all designation used to describe the unequal sharing (asymmetric division) of soluble cytosolic components between the mother and daughter cells (St Johnston 1995; Bonasio et al. 2010). The unequal aspect of sharing may be due to simple stochasticity (when the absolute number of the components is sufficiently low to allow differences to arise from statistical chance) (Bonasio et al. 2010; Cerulus et al. 2016) or from specialist biological mechanisms that either preferentially retain damaged components (St Johnston 1995; McFaline-Figueroa et al. 2011; Yang et al. 2015) or preferentially promote the uptake of advantageous or required components able to facilitate the best possible outcome for the nascent daughter cell (McFaline-Figueroa et al. 2011). The chemical lifetime of these added components has dramatic consequences for their ability to act as trans-generational epigenetic factors (Fitz-James and Cavalli 2022). As shown from microinjection experiments, whilst relatively short-lived components, such as various coding/noncoding RNA or enzymes can influence the immediate growth behaviour of the daughter cell,Footnote 25 they do not necessarily show particularly strong genetic linkages to subsequent generations (Lim and Brunet 2013; Fitz-James and Cavalli 2022). However, long-lived, structurally persistent states, able to perpetuate and replicate themselves over the time-course of the cell-division cycle, are themselves able to be inherited and are therefore capable of showing strong epigenetic linkage patternsFootnote 26 (Wickner et al. 2015). In both yeast, and bacteria, the original prototypic cytosol-based epigenetic factors were small pieces of circularized nucleic acid known as plasmids (Wickner and Leibowitz 1977; Gunge 1983). Acquisition or loss of a plasmid was shown to confer additional traits such as antibiotic resistance or sexual mating preference (Gunge 1983).
Somewhat more recently, a second class of cytosolic epigenetic factor comprised of amyloid polymer has been found to be common in certain yeast and mold species (Wickner 1994; Wickner et al. 1995, 1999, 2021; Dos Reis et al. 2002; Tuite and Serio 2010; Halfmann et al. 2012). Referred to as yeast (and fungal) prions,Footnote 27 these epigenetic components are physically constituted by structurally persistent amyloid homopolymers and due to their ability to effect a phenotype, are sometimes referred to as protein genes (Wickner et al. 2015). The question as to whether or not these new classes of amyloid-based epigenetic components act to improve organism fitness by playing a positive role (Halfmann et al. 2012; Garcia and Jarosz 2014; Wang et al. 2017), decrease organism fitness thereby acting as a disease (Wickner et al. 2011), or even constitute an as yet unknown biochemical function, is still an open one (Tuite and Serio 2010). In our model we left this question open by parameterizing the free concentration of amino acids in terms of the total build-up of monomer within prion form (Eq. 6). Growth rates could be similarly parametrized in terms of either total prion levels or the amount of prion of a particular size (Hall and Edskes 2009). Despite an ongoing debate over the role played by prions, the widespread existence of a range of different types of yeast prions, and the biomolecular components that interact with them, has been concretely established (Wickner et al. 2015, 2021). Aside from the [PSI+], [URE2] and [RNQ1] prion elements already discussed in this work there have been approximately ten other types of yeast prions discovered (with each prion based on a different amyloid protein component) (Wickner et al. 2015). Alongside research on the prion components themselves, has been the discovery of biochemical factors that interact with prions to modulate their behaviour to achieve the following functional outcomes (i) prion re-solubilization, (ii) prion degradation, (iii) prion selective segregation and (iv) prion sequestration (Wickner et al. 2015). Within yeast, a range of protein regulatory subsystems have been shown to be active in these different forms of prion modulation with a non-exhaustive list including the following; chaperone systems (Verghese et al. 2012; Chernova et al. 2017), ubiquitin–proteasome system (Berner et al. 2018), autophagy system (Suzuki and Ohsumi 2007), aggresome systems (Miller et al. 2015); vacuoles (the yeast lysosome) (Armstrong 2010); system for asymmetric segregation of damaged proteins (Coelho and Tolić, 2015), GET pathway proteins (Borgese and Fasana 2011) and the Btn2–Cur1 system (Wickner et al. 2014). Interestingly, MIL-CELL offers the potential to replicate the functional outcome from the up or down-regulation of these various prion-modifying systems through specification and parameterization of the governing model constants. Indeed, with approximately twenty alterable parameters and initial conditions the high dimensionality of the search space within MIL-CELL simulations is ripe for parameterization by experiment.
Potential wider application of MIL-CELL to disease and non-disease cellular processes
Due to the generality of the modelling approach used to describe both cell growth/division, and the chemical behavior of the cytosolic component, MIL-CELL has potentially significant capabilities to provide insight into a range of other cellular phenomenon. In this section, I discuss some of these additional capabilities in terms of MIL-CELL’s potential use for casting light on disease and non-disease cellular processes.
Using MIL-CELL to investigate disease at the cellular level Although not limited to the following we discuss MIL-CELL’s applicability to, amyloidosis, cancer and mitochondrial dysfunction. (i) Amyloidosis: As of 2022 there are 42 proteins known to form amyloid in humans (Buxbaum et al. 2022). The various amyloidosis diseases (including Alzheimer’s disease, Type 2 diabetes and cardiac amyloidosis) all involve the formation of significant amounts of amyloid aggregates which interact negatively with tissue due to either aggregates possessing an intrinsic cytotoxicity, or through physical effects manifested from amyloid infiltration into the tissue space, changing its material properties and diminishing its normal function (Hardy and Higgins 1992; Merlini and Bellotti 2003; Hall and Edskes 2009, 2012; Martinez-Naharro et al. 2018; Fornari et al. 2019). MIL-CELL could effectively replicate such empirical experimental realities by including the export of monomer from a cell to the interstitial space with a subsequent description of its diffusion and aggregation within that space by use of either compartment modelling (Craft et al. 2002) or sets of partial differential equations reflecting two-dimensional diffusion reaction equations (Matthäus 2006). Cell growth rates and death could be made functions of the extent and length of exposure to amyloid in the interstitial space. Although the amyloidosis diseases were originally characterized by the extracellular formation and deposition of amyloid (Buxbaum et al. 2022) the last thirty years has seen both a growing recognition of the intracellular accumulation and processing of amyloid in diseases such as Alzheimer’s (Hardy and Higgins 1992; Glabe 2001) via intracellular aggregation mechanisms and endosomal and lysosomal transport of external amyloid (Bayer and Wirths 2010). In addition, there are a number of amyloidosis-related disease states which primarily involve intracellular accumulation of amyloid aggregates, such as Alzheimer’s related tau amyloidosis (Nizynski et al. 2017), Parkinson’s disease-related α-synuclein amyloid formation (Lücking 2000) and Huntington’s disease-related huntingtin amyloid formation (Ross and Tabrizi 2011). In its present state, MIL-CELL could be used to investigate the effect of various kinetic mechanisms on the time course and development of amyloid within a cell space (e.g. see Fig. 4) and tying the build-up of amyloid beyond a certain level to cell toxicity and cell death. With very slight extension MIL-CELL could also be adapted to feature amyloid transfer between cells via mechanisms dependent on either cell rupture following death or transfer via exosome formation (Steiner et al. 2011). (ii) Cancer: Due to its use of a particle model for cell growth and division MIL-CELL holds significant potential for use in the investigation of the two basic sub-fields of cancer biology described as initiation and migration (Bertram 2000; Riggi et al. 2018). Initiation of cancer involves the flipping of one of a large number of genetic/biochemical switches which transforms a previously healthy cell (having defined growth and division patterns and specific cellular morphology) to a cancerous cell that typically lacks tight control of growth and division and loses its normal cell morphology and respect of local confluence (Bertram 2000). Such a situation could be reconciled within MIL-CELL by individually assigning cells a local confluence parameter ε (Eqs. 2c, 2d) (with the value determined by either a stochastic incidence, a defined neighbor relationship or position within a colony or the build up of a chemical component) and local growth rates and local variability terms (Eqs. 1, 2a, 2b, 3, 4). A hallmark of transformed cancer cells is their tendency to undergo migration and spread through the body in a process known as metastasis (Riggi et al. 2018). Their departure from the tissue of origin to the bloodstream (intravasation) and their movement from the bloodstream into a new tissue (extravasation) involves purposeful migration through tissue with the necessary displacement of surrounding cells (Riggi et al. 2018). Directed motion within MIL-CELL could be simply implemented by assigning a semi-random drift velocity to a 'transformed' cell growing within the colony. (iii) Mitochondrial dysfunction: Existing within every eukaryotic cell, mitochondria are semi-autonomous organelles that contain their own genome and which coordinate their growth and replication with that of their host cell (Ernster and Schatz 1981; Bock and Tait 2020). Mitochondria are largely responsible for the production of ATP (Adenosine Tri-Phosphate) within every eukaryotic cell by virtue of the fact that they contain the biochemical machinery necessary for carrying out the three essential metabolic processes known as the tricarboxylic acid cycle (TCA—breakdown of citric acid) (Ernster and Schatz 1981), β-oxidation (breakdown of fatty acids) (Ernster and Schatz 1981) and oxidative phosphorylation (coupling the oxidation of high energy reduced cofactor (NADH—nicotinamide adenine dinucleotide) via oxygen to form water and oxidized cofactor (NAD+) with the production of 3 ATP) (Ernster and Schatz 1981). Yeast cells possess a small number of mitochondria (~ 10) (Vevea et al. 2014), mid-sized mammalian eukaryotic cells can contain hundreds to thousands (Dewey and Fuhr 1976) whilst large cells, such as neurons, can contain thousands to millions (Misgeld and Schwarz 2017). Some forms of intracellular amyloid have been observed to both directly, and indirectly, damage mitochondria (Bayer and Wirths 2010). Additionally, asymmetric transfer of mitochondria during cell division can result in significant differences in growth rate between mother and daughter cells as well as contributing to numerous diseases (such as cancer and also, in a somewhat circular fashion, amyloidosis, amongst many others) (Annesley and Fisher 2019). In its current state MIL-CELL has the ability to mimic mitochondrial replication inside the cell and transfer within a dividing cell population (by setting CA1 > 0, fG > 0, (kA1)αβ > 0, bG >0, bA1 >0 and fN = fA1 = fA2 = 0) and also to tie cell growth rate to mitochondrial number. Further developments could involve the explicit specification of mitochondrial damage via amyloid accumulation and preferential retainment/donation of such damaged mitochondria during cell division.
Using MIL-CELL to investigate non-disease processes at the cellular level As a model of cell growth MIL-CELL holds potential for investigating a range of fundamental aspects of cell biology not necessarily associated with disease. Without restriction, we introduce three open questions in cell biology to which MIL-CELL could provide useful insight, namely cell variability within a clonal population, temporal and morphological heterogeneity in cellular differentiation pathways and differences in mechanisms of cell death dependent on generational versus linear aging. (i) Cell variability: Cultured cells are often used as the first type of in vivo model for testing the efficacy of a potential drug, the cytotoxicity or mutagenicity of a dangerous substance, or as a production platform in the creation of a useful biochemical (Stevens and Baker 2009; Hong et al. 2018). To eliminate sources of variability, the test culture is typically produced via dilutional plating to ensure a single clonal population (Hong et al. 2018). Despite the existence of an isogenic population the individual cells within the culture will exhibit variation not just in fundamental observable traits, such as mRNA and protein expression, cell size and morphology and cell growth and division rates (to name but a few) (Stockholm et al. 2007), but will also exhibit variation in response to the drug or dangerous compound being tested (Moore et al. 2018). Knowledge of the functional form of this variation and how it evolves over time is necessary for assessing confidence in experimental results (Stockholm et al. 2007; Moore et al. 2018; Hong et al. 2018). MIL-CELL features a novel implementation of the variability of cell growth rate constants based on random sampling from a distribution produced by recursive formula updated with each cell generation (Eqs. 3 and 4). It will prove interesting to see how accurately this formulation can replicate variability recorded from microscopy or single-cell cytometry studies (Stockholm et al. 2007; Moore et al. 2018). (ii) Temporal and morphological heterogeneity in cellular differentiation pathways: Developmental biology, such as is typified by the production of an entire organism from a single fertilized egg, is a process that requires exquisite spatial and temporal control of cell the division and differentiation pathways as well as extremely robust mechanisms for dealing with environmental variation at different stages of the developmental process (Oates et al. 2009). Although originally cast in terms of a culture of single-cell organisms one obvious extension of the MIL-CELL program would be to allow for both cell differentiation and cell-to-cell association to provide a primitive model of tissue formation (Keller 2013). Such programmed differentiation could be age based (either chronological or replicational) or position based (e.g. determined in relation to time spent at the interior or edge of the culture/proximity to a new class of differentiated cell) or the cell’s location within a gradient of externally derived environmental signals (Oates et al. 2009; Keller 2013)). A priori developmental programming combined with rapid simulation within MIL-CELL offers the prospect of identifying stable robust developmental strategies. (iii) Cell death: In a multicellular organism, regulation of the process of cell death is an absolute requirement for both its correct development and continued maintenance/perpetuation (Doherty and Baehrecke 2018). Cell death can occur in one of three general ways, apoptosis (purposeful breakdown of the genetic material), autophagy (literally ‘self-eating’ due to the formation of a large internal double membraned vacuolar body known as the autophagosome which engulfs and transports cellular contents to the lysosome for subsequent breakdown) and necrosis (cell death resulting from irreparable cellular damage caused by injury or disease) (Doherty and Baehrecke 2018) with the first two of these considered as alternative methods of programmed cell death (Fuchs and Steller 2011; Doherty and Baehrecke 2018). The relationship between these three types of cell death to both the age of a cell (chronological and replicational) and its exposure to an external or internal signal is an area rich in potential for investigation and MIL-CELL has much of the required mathematical formulation in place to provide insight into these fields.
Conclusions
The increasing availability of computing power holds significant potential to aid with the interpretation of difficult-to-understand experiments of complex biological phenomena (e.g. Hall et al. 2018; Cerulus et al. 2016; Hall 2020b; LeMarre et al. 2020). Effectively established by Wickner in the early 1990s, the sub-field of epigenetic inheritance conferred by yeast amyloid prion growth and transmission within a dividing population of yeast cells is a particularly mature example of such complex biological phenomena (Wickner et al. 1995). By coupling a multiscale dynamic model of cell growth and amyloid kinetics together with the powers of a relational database, the MIL-CELL program described within the current paper (and available for download within the supplementary file), will prove useful in the interpretation of the results of experiments involving amyloid transmission between dividing cells. In cases where such direct comparison is not immediately available due to current experimental limitations, it is hoped that the simulated data streams available within MIL-CELL will encourage/assist the yeast experimental biologist community towards the acquisition of data at ever increasing extents of resolution within the spatial, temporal and cellular (lineage) metrological domains. Recently, the asymmetric transmission of both amyloid and other cytosolic components, has been understood as holding importance across many areas of cell biology, from fields such as epigenetics (as discussed in this work) to cellular differentiation, cellular aging and death and the study of diseases such as cancer, mitochondrial dysfunction and amyloidosis. We hope that the MIL-CELL program may also assist in shedding light on these additional topics in the future.
Data availability
Software developed in this paper can be downloaded from either the supplementary materials or from the url listed on the front page.
Notes
And indeed from higher ploidy states.
The term epigenetics was first coined by Waddington in 1942 as he attempted to jointly study the relatively new fields of embryology and genetics (epigenetics = ‘epigenesis’ + ‘genetics’) (Waddington 1942). A simple operational definition of an epigenetic factor is something that can effect a phenotypic trait (that can be passed on to offspring) but which is not simply specified by a linear chromosomal gene sequence of the parent. This operational description is inclusive of the two standard definitions of epigenetic factors discussed more carefully by Haig (2004). Molecular epigenetic factors can be considered as trans or cis. A ‘trans’ epigenetic molecular factor is transmitted via partitioning of the cytosol during cell division, whereas ‘cis’ epigenetic molecular factors are physically associated with the chromosomal DNA and are passed on via chromosomal segregation during cell division (Bonasio et al. 2010).
Although mentioned here due to the fact that it is a common epigenetic factor, DNA methylation does not occur to an appreciable extent in yeast (Tang et al. 2012).
Yeast can be engineered to contain genes with a premature translation stop codon. Due to Sup35's role as a translation arrest factor (Didichenko et al. 1991; Stansfield et al. 1995) the proteins coded by such genes with a premature stop codon can only be expressed when Sup35 is non-functional, such as is the case when Sup35 exists as an insoluble inactive component within an amyloid prion. Using this reporter mechanism a range of functional markers are possible with the standard involving an ADE1 gene mutant containing a premature stop codon. The functional enzyme produced from the ADE1 gene catalyses the enzymatic cleavage of a red coloured intermediate in the adenine biosynthetic pathway. Presence of the functional Sup35 monomer prevents expression of the ADE1 gene product thereby affording the yeast a red color and necessitating that the yeast be grown in media containing the adenine (see Fig. 5).
The yeast vacuole system is the equivalent of the lysosome system in mammalian eukaryotic cells.
At a time sufficiently progressed that the likelihood of occurrence of the kinetic transition at zero local density is one i.e. P(I → J, ρlocal = 0, t → ∞ = 1)
We have adopted this latter physical viewpoint of the resistance to insertion/growth to yeast segments i.e. the primary resistance is generated by pushing other yeast out of the way due to either their interaction with the surface or fluid surrounds.
By reduced we mean \(\Delta E^{*} = \left(\frac{\Delta E}{kT}\right)\) with k being the Boltzmann constant and T the absolute temperature. We acknowledge that the Boltzmann distribution may not be the most appropriate term due to the macroscopic nature of the particles involved (e.g. cells). However, even if applied imperfectly, the selection process is well formulated and its consistent application is sufficient to provide insight into the internal vs external growth of cells within or around the yeast colony.
Yeast movement is broken down into the positive ┴ and negative ┬ directions perpendicular to the plane of insertion with the total number of yeast segments having to be ‘pushed’ in these respective directions denoted as N(┴) and N(┬). If N(┴) = N(┬) a 50:50 random split is made between moving the N(┴) or N(┬) set. In the case that the yeast growth is effectively fixed in place on the plate i.e. ε → ∞ then the Metropolis selection criteria reduces to one of yeast particle non-overlap, a situation requiring that the distance, dmn, between any two yeast segment centers*, Cm(x,y,z) and Cn(x,y,z), is larger than the sum of their respective radii, Rm and Rn,\(P (\mathrm{I j},{}_{\mathrm{local}}, t \infty ) \left\{\begin{array}{c} = 1\iff {d}_{m,n}\ge {R}_{m}+{R}_{n} \\ = 0\iff {d}_{m,n}< {R}_{m}+{R}_{n}\end{array}\right.\). (*To make the computation easier each mature yeast is considered as containing two spherical segments within the rectangular solid of aspect ratio 2).
An alternative point of view is that it is the loss of functional monomer that causes a deleterious loss of function.
We will speculate on the mechanism of the self-limitation in the discussion.
For simplicity we set n = 2. This simplifying assumption has been discussed elsewhere (Hirota et al. 2019).
The nascent daughter is referred to as the ‘bud’ prior to septum closure.
With the exception that the partition term for mass concentration, the number concentration terms are multiplied by their average molecular weight i.e. (Ci)Q < iAV > Q.
Bearing on mind that we are solely considering monolayer growth in this paper in the form of yeast growing in a two-dimensional restricted space.
In practice yeast are plated on media containing guanidine HCl which prevents Hsp104-based cleavage of amyloid prions. Single colonies are selected and then differentially replated on media containing / media lacking adenine, ensuring that only yeast containing amyloid prions will be able to be selected.
SEM measurements can reveal the bud scars in mother yeast cells produced at each cell division (Chant and Pringle 1995). Bud scars can also be visualized by fluorescence microscopy upon staining yeast with calcofluor white.
Another problem is the differential transport and competition for solutes from the growth medium that is associated with three-dimensional cell growth (Vulin et al. 2014).
Despite developing a perhaps superior digital indexing system to the one described in the current paper.
In the role of an initial condition.
When they play some positive or negative role in cell growth and can therefore produce an observable phenotype.
The prion term was first coined by Stanley Prusiner who discovered the amyloid-based molecular origins of set of closely related disease spongiform encephalopathies that are characterized by chronic brain wasting, dementia and eventually death (Scrapie in sheep, BSE (bovine spongiform encephalopathy) in cows, and Kuru and variant CJD (Creutzfeld-Jakob disease) in humans (amongst others) (Prusiner 1982).
References
Adamcik J, Jung JM, Flakowski J, De Los Rios P, Dietler G, Mezzenga R (2010) Understanding amyloid aggregation by statistical analysis of atomic force microscopy images. Nat Nanotechnol 5(6):423–428. https://doi.org/10.1038/nnano.2010.59
Aguzzi A, Sigurdson CJ (2004) Antiprion immunotherapy: to suppress or to stimulate? Nat Rev Immunol 4(9):725–736. https://doi.org/10.1038/nri1437
Aigle M, Lacroute F (1975) Genetical aspects of [URE3], a non-mitochondrial, cytoplasmically inherited mutation in yeast. Mol Gen Genet MGG 136(4):327–335. https://doi.org/10.1007/BF00341717
Alberti S, Halfmann R, Lindquist S (2010) Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast. Methods in enzymology, vol 470. Academic Press, Cambridge, pp 709–734. https://doi.org/10.1016/S0076-6879(10)70030-6
Andrews B, Boone CM, Davis T, Fields S (eds) (2016) Budding yeast: a laboratory manual. Cold Spring Harbor Laboratory Press, New York
Annesley SJ, Fisher PR (2019) Mitochondria in health and disease. Cells 8(7):680. https://doi.org/10.3390/cells8070680
Armstrong J (2010) Yeast vacuoles: more than a model lysosome. Trends Cell Biol 20(10):580–585. https://doi.org/10.1016/j.tcb.2010.06.010
Auer S, Meersman F, Dobson CM, Vendruscolo M (2008) A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates. PLoS Comput Biol 4(11):e1000222. https://doi.org/10.1371/journal.pcbi.1000222
Banwarth-Kuhn M, Sindi S (2019) Multi-scale mathematical modeling of prion aggregate dynamics and phenotypes in yeast colonies. In: Apolipoproteins, triglycerides and cholesterol. IntechOpen, London
Banwarth-Kuhn M, Collignon J, Sindi S (2020) Quantifying the biophysical impact of budding cell division on the spatial organization of growing yeast colonies. Appl Sci 10(17):5780. https://doi.org/10.3390/app10175780
Banwarth-Kuhn M, Sindi S (2020) How and why to build a mathematical model: A case study using prion aggregation. J Biol Chem 295(15): pp.5022–5035. https://doi.org/10.1074/jbc.REV119.009851
Barton AA (1950) Some aspects of cell division in Saccharomyces cerevisiae. Microbiology 4(1):84–86. https://doi.org/10.1099/00221287-4-1-84
Bayer TA, Wirths O (2010) Intracellular accumulation of amyloid-Beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer’s disease. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2010.00008
Berner N, Reutter KR, Wolf DH (2018) Protein quality control of the endoplasmic reticulum and ubiquitin–proteasome-triggered degradation of aberrant proteins: yeast pioneers the path. Annu Rev Biochem 87:751–782. https://doi.org/10.1146/annurev-biochem-062917-012749
Bertram JS (2000) The molecular biology of cancer. Mol Aspects Med 21(6):167–223. https://doi.org/10.1016/s0098-2997(00)00007-8
Beun LH, Albertazzi L, van der Zwaag D, de Vries R, Cohen Stuart MA (2016) Unidirectional living growth of self-assembled protein nanofibrils revealed by super-resolution microscopy. ACS Nano 10(5):4973–4980. https://doi.org/10.1021/acsnano.6b01017
Binger KJ, Pham CL, Wilson LM, Bailey MF, Lawrence LJ, Schuck P, Howlett GJ (2008) Apolipoprotein C-II amyloid fibrils assemble via a reversible pathway that includes fibril breaking and rejoining. J Mol Biol 376(4):1116–1129. https://doi.org/10.1016/j.jmb.2007.12.055
Bishop MF, Ferrone FA (1984) Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. Biophys J 46(5):631–644. https://doi.org/10.1016/S0006-3495(84)84062-X
Bitterman KJ, Medvedik O, Sinclair DA (2003) Longevity regulation in Saccharomyces cerevisiae: linking metabolism, genome stability, and heterochromatin. Microbiol Mol Biol Rev 67(3):376–399. https://doi.org/10.1128/mmbr.67.3.376-399.2003
Bladen HA, Nylen MU, Glenner GG (1966) The ultrastructure of human amyloid as revealed by the negative staining technique. J Ultrastruct Res 14(5–6):449–459. https://doi.org/10.1016/S0022-5320(66)80075-8
Bock FJ, Tait SW (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21(2):85–100. https://doi.org/10.1038/s41580-019-0173-8
Bonasio R, Tu S, Reinberg D (2010) Molecular signals of epigenetic states. Science 330(6004):612–616. https://doi.org/10.1126/science.1191078
Bony M, Thines-Sempoux D, Barre P, Blondin B (1997) Localization and cell surface anchoring of the Saccharomyces cerevisiae flocculation protein Flo1p. J Bacteriol 179(15):4929–4936. https://doi.org/10.1128/jb.179.15.4929-4936.1997
Borgese N, Fasana E (2011) Targeting pathways of C-tail-anchored proteins. Biochim Biophys Acta (BBA) Biomembr 1808(3):937–946. https://doi.org/10.1016/j.bbamem.2010.07.010
Brachmann A, Baxa U, Wickner RB (2005) Prion generation in vitro: amyloid of Ure2p is infectious. EMBO J 24(17):3082–3092. https://doi.org/10.1038/sj.emboj.7600772
Brachmann A, Toombs JA, Ross ED (2006) Reporter assay systems for [URE3] detection and analysis. Methods 39(1):35–42. https://doi.org/10.1016/j.ymeth.2006.04.008
Burggren W (2016) Epigenetic inheritance and its role in evolutionary biology: re-evaluation and new perspectives. Biology 5(2):24. https://doi.org/10.3390/biology5020024
Buxbaum JN, Dispenzieri A, Eisenberg DS, Fändrich M, Merlini G, Saraiva MJ, Sekijima Y, Westermark P (2022) Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid 29(4):213–219. https://doi.org/10.1080/13506129.2022.2147636
Byrne LJ, Cox BS, Cole DJ, Ridout MS, Morgan BJ, Tuite MF (2007) Cell division is essential for elimination of the yeast [PSI+] prion by guanidine hydrochloride. Proc Natl Acad Sci 104(28):11688–11693. https://doi.org/10.1073/pnas.0701392104
Byrne LJ, Cole DJ, Cox BS, Ridout MS, Morgan BJ, Tuite MF (2009) The number and transmission of [PSI+] prion seeds (propagons) in the yeast Saccharomyces cerevisiae. PLoS ONE 4(3):e4670. https://doi.org/10.1371/journal.pone.0004670
Cerulus B, New AM, Pougach K, Verstrepen KJ (2016) Noise and epigenetic inheritance of single-cell division times influence population fitness. Curr Biol 26(9):1138–1147. https://doi.org/10.1016/j.cub.2016.03.010
Chant J, Pringle JR (1995) Patterns of bud-site selection in the yeast Saccharomyces cerevisiae. J Cell Biol 129(3):751–765. https://doi.org/10.1083/jcb.129.3.751
Chernova TA, Wilkinson KD, Chernoff YO (2017) Prions, chaperones, and proteostasis in yeast. Cold Spring Harbor Perspecti Biol 9(2):a023663. https://doi.org/10.1101/cshperspect.a023663
Coelho M, Tolić IM (2015) Asymmetric damage segregation at cell division via protein aggregate fusion and attachment to organelles. BioEssays 37(7):740–747. https://doi.org/10.1002/bies.201400224
Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183(4669):1202–1203. https://doi.org/10.1038/1831202a0
Cole DJ, Morgan BJ, Ridout MS, Byrne LJ, Tuite MF (2004) Estimating the number of prions in yeast cells. Math Med Biol J IMA 21(4):369–395. https://doi.org/10.1093/imammb/21.4.369
Come JH, Fraser PE, Lansbury PT Jr (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci 90(13):5959–5963. https://doi.org/10.1073/pnas.90.13.59
Coschigano PW, Magasanik B (1991) The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione S-transferases. Mol Cell Biol 11(2):822–832. https://doi.org/10.1128/mcb.11.2.822-832.1991
Courchesne WE, Magasanik B (1988) Regulation of nitrogen assimilation in Saccharomyces cerevisiae: roles of the URE2 and GLN3 genes. J Bacteriol 170(2):708–713. https://doi.org/10.1128/jb.170.2.708-713.1988
Cox BS (1965) [PSI], a cytoplasmic suppressor of super-suppressor in yeast. Heredity 20:505–521. https://doi.org/10.1038/hdy.1965.65
Craft DL, Wein LM, Selkoe DJ (2002) A mathematical model of the impact of novel treatments on the Aβburden in the Alzheimer’s brain, CSF and plasma. Bull Math Biol 64(5):1011–1031. https://doi.org/10.1006/bulm.2002.0304
Davie JR, Saunders CA, Walsh JM, Weber SC (1981) Histone modifications in the yeast S. cerevisiae. Nucleic Acids Res 9(13):3205–3216. https://doi.org/10.1093/nar/9.13.3205
Derkatch IL, Chernoff YO, Kushnirov VV, Inge-Vechtomov SG, Liebman SW (1996) Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics 144(4):1375–1386. https://doi.org/10.1093/genetics/144.4.1375
Derkatch IL, Bradley ME, Zhou P, Chernoff YO, Liebman SW (1997) Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics 147(2):507–519. https://doi.org/10.1093/genetics/147.2.507
Derkatch IL, Bradley ME, Masse SV, Zadorsky SP, Polozkov GV, Inge-Vechtomov SG, Liebman SW (2000) Dependence and independence of [PSI+] and [PIN+]: a two-prion system in yeast? EMBO J 19(9):1942–1952. https://doi.org/10.1093/emboj/19.9.1942
Dewey WC, Fuhr MA (1976) Quantification of mitochondria during the cell cycle of Chinese hamster cells. Exp Cell Res 99(1):23–30. https://doi.org/10.1016/0014-4827(76)90675-3
Didichenko SA, Ter-Avanesyan MD, Smirnov VN (1991) Ribosome-bound EF-1α-like protein of yeast Saccharomyces cerevisiae. Eur J Biochem 198:705–711. https://doi.org/10.1111/j.1432-1033.1991.tb16070.x
Doel SM, McCready SJ, Nierras CR, Cox BS (1994) The dominant PNM2-mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137(3):659–670. https://doi.org/10.1093/genetics/137.3.659
Doherty J, Baehrecke EH (2018) Life, death and autophagy. Nat Cell Biol 20(10):1110–1117. https://doi.org/10.1038/s41556-018-0201-5
Dos Reis S, Coulary-Salin B, Forge V, Lascu I, Bégueret J, Saupe SJ (2002) The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils. J Biol Chem 277(8):5703–5706. https://doi.org/10.1074/jbc.M110183200
Douglas PM, Treusch S, Ren HY, Halfmann R, Duennwald ML, Lindquist S, Cyr DM (2008) Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci 105(20):7206–7211. https://doi.org/10.1073/pnas.0802593105
Drasdo D, Höhme S (2005) A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Phys Biol 2(3):133. https://doi.org/10.1088/1478-3975/2/3/001
Duina AA, Miller ME, Keeney JB (2014) Budding yeast for budding geneticists: a primer on the Saccharomyces cerevisiae model system. Genetics 197(1):33–48. https://doi.org/10.1534/genetics.114.163188
Eaglestone SS, Ruddock LW, Cox BS, Tuite MF (2000) Guanidine hydrochloride blocks a critical step in the propagation of the prion-like determinant [PSI+] of Saccharomyces cerevisiae. Proc Natl Acad Sci 97(1):240–244. https://doi.org/10.1073/pnas.97.1.240
Eanes ED, Glenner GG (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16(11):673–677. https://doi.org/10.1177/16.11.673
Eden M (1960) A two-dimensional growth process. In: Proceedings of 4th Berkeley symposium mathematical statistics and probability, vol 4. Univ. California Press, Berkeley, p 223. https://digitalassets.lib.berkeley.edu/math/ucb/text/math_s4_v4_article-15.pdf
Edskes HK, Gray VT, Wickner RB (1999) The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci 96(4):1498–1503. https://doi.org/10.1073/pnas.96.4.149
Eigen M (1996) Prionics or the kinetic basis of prion diseases. Biophys Chem 63(1):A1–A18. https://doi.org/10.1016/S0301-4622(96)02250-8
Eisenberg DS, Sawaya MR (2017) Structural studies of amyloid proteins at the molecular level. Annu Rev Biochem 86(1):69–95. https://doi.org/10.1146/annurev-biochem-061516-045104
Ernster L, Schatz G (1981) Mitochondria: a historical review. J Cell Biol 91(3):227s–255s. https://doi.org/10.1083/jcb.91.3.227s
Fitz-James MH, Cavalli G (2022) Molecular mechanisms of transgenerational epigenetic inheritance. Nat Rev Genet 23(6):325–341. https://doi.org/10.1038/s41576-021-00438-5
Flyvbjerg H, Jobs E, Leibler S (1996) Kinetics of self-assembling microtubules: an “inverse problem” in biochemistry. Proc Natl Acad Sci 93(12):5975–5979. https://doi.org/10.1073/pnas.93.12.5975
Fornari S, Schäfer A, Jucker M, Goriely A, Kuhl E (2019) Prion-like spreading of Alzheimer’s disease within the brain’s connectome. J R Soc Interface 16(159):20190356. https://doi.org/10.1098/rsif.2019.0356
Forsburg SL, Nurse P (1991) Cell cycle regulation in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe. Annu Rev Cell Biol 7(1):227–256. https://doi.org/10.1146/annurev.cb.07.110191.001303
Fuchs Y, Steller H (2011) Programmed cell death in animal development and disease. Cell 147(4):742–758. https://doi.org/10.1016/j.cell.2011.10.033
Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197(4307):943–960. https://doi.org/10.1126/science.14230
Garcia DM, Jarosz DF (2014) Rebels with a cause: molecular features and physiological consequences of yeast prions. FEMS Yeast Res 14(1):136–147. https://doi.org/10.1111/1567-1364.12116
Glabe C (2001) Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease. J Mol Neurosci 17(2):137–145. https://doi.org/10.1385/JMN:17:2:137
Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3):885–890. https://doi.org/10.1016/S0006-291X(84)80190-4
Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD (1974) β-pleated sheet fibrils a comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem 22(12):1141–1158. https://doi.org/10.1177/22.12.1141
Greene LE, Saba F, Silberman RE, Zhao X (2020) Mechanisms for curing yeast prions. Int J Mol Sci 21(18):6536. https://doi.org/10.3390/ijms21186536
Griffith JS (1967) Nature of the scrapie agent: Self-replication and scrapie. Nature 215(5105):1043–1044. https://doi.org/10.1038/2151043a0
Gunge N (1983) Yeast DNA plasmids. Annu Rev Microbiol 37(1):253–276. https://doi.org/10.1146/annurev.mi.37.100183.001345
Haig D (2004) The (dual) origin of epigenetics. Cold Spring Harbor Symp Quant Biol 69:67–70. https://doi.org/10.1101/sqb.2004.69.67
Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S (2012) Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 482(7385):363–368. https://doi.org/10.1038/nature10875
Hall D (2003) The effects of Tubulin denaturation on the characterization of its polymerization behavior. Biophys Chem 104(3):655–682. https://doi.org/10.1016/S0301-4622(03)00040-1
Hall D (2012) Semi-automated methods for simulation and measurement of amyloid fiber distributions obtained from transmission electron microscopy experiments. Anal Biochem 421(1):262–277. https://doi.org/10.1016/j.ab.2011.10.012
Hall D (2020a) A simple method for modeling amyloid kinetics featuring position biased fiber breakage. Biophys Physicobiol 17:30–35. https://doi.org/10.2142/biophysico.BSJ-2020003
Hall D (2020b) On the nature of the optimal form of the holdase-type chaperone stress response. FEBS Lett 594(1):43–66. https://doi.org/10.2142/biophysico.BSJ-2020003
Hall D, Edskes H (2004) Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection. J Mol Biol 336(3):775–786. https://doi.org/10.1016/j.jmb.2003.12.004
Hall D, Edskes H (2009) A model of amyloid’s role in disease based on fibril fracture. Biophys Chem 145(1):17–28. https://doi.org/10.1016/j.bpc.2009.08.004
Hall D, Edskes H (2012) Computational modeling of the relationship between amyloid and disease. Biophys Rev 4(3):205–222. https://doi.org/10.1007/s12551-012-0091-x
Hall D, Hirota N (2009) Multi-scale modelling of amyloid formation from unfolded proteins using a set of theory derived rate constants. Biophys Chem 140(1–3):122–128. https://doi.org/10.1016/j.bpc.2008.11.013
Hall D, Hoshino M (2010) Effects of macromolecular crowding on intracellular diffusion from a single particle perspective. Biophys Rev 2(1):39–53. https://doi.org/10.1007/s12551-010-0029-0
Hall D, Minton AP (2002) Effects of inert volume-excluding macromolecules on protein fiber formation. I. Equilibrium models. Biophys Chem 98(1–2):93–104. https://doi.org/10.1016/S0301-4622(02)00087-X
Hall D, Minton AP (2004) Effects of inert volume-excluding macromolecules on protein fiber formation. II. Kinetic models for nucleated fiber growth. Biophys Chem 107(3):299–316. https://doi.org/10.1016/j.bpc.2003.09.016
Hall CK, Nguyen HD, Marchut AJ, Wagoner V (2006) Simulations of protein aggregation. Misbehaving proteins. Springer, New York, pp 47–77. https://doi.org/10.1007/978-0-387-36063-8_3
Hall D, Kardos J, Edskes H, Carver JA, Goto Y (2015) A multi-pathway perspective on protein aggregation: implications for control of the rate and extent of amyloid formation. FEBS Lett 589(6):672–679. https://doi.org/10.1016/j.febslet.2015.01.032
Hall D, Zhao R, So M, Adachi M, Rivas G, Carver JA, Goto Y (2016) Recognizing and analyzing variability in amyloid formation kinetics: simulation and statistical methods. Anal Biochem 510:56–71. https://doi.org/10.1016/j.ab.2016.07.013
Hall D, Kinjo AR, Goto Y (2018) A new look at an old view of denaturant induced protein unfolding. Anal Biochem 542:40–57. https://doi.org/10.1016/j.ab.2017.11.011
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256(5054):184–185. https://doi.org/10.1126/science.1566067
Hartwell LH (1974) Saccharomyces cerevisiae cell cycle. Bacteriol Rev 38(2):164–198. https://doi.org/10.1128/br.38.2.164-198.1974
Hartwell LH, Unger MW (1977) Unequal division in Saccharomyces cerevisiae and its implications for the control of cell division. J Cell Biol 75(2):422–435. https://doi.org/10.1083/jcb.75.2.422
Heldt CL, Zhang S, Belfort G (2011) Asymmetric amyloid fibril elongation: a new perspective on a symmetric world. Proteins Struct Funct Bioinform 79(1):92–98. https://doi.org/10.1002/prot.22861
Heydari AA, Sindi SS, Theillard M (2022) Conservative finite volume method on deforming geometries: the case of protein aggregation in dividing yeast cells. J Comput Phys 448:110755. https://doi.org/10.1016/j.jcp.2021.110755
Hirota N, Edskes H, Hall D (2019) Unified theoretical description of the kinetics of protein aggregation. Biophys Rev 11(2):191–208. https://doi.org/10.1007/s12551-019-00506-5
Hofrichter J, Ross PD, Eaton WA (1974) Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natl Acad Sci 71(12):4864–4868. https://doi.org/10.1073/pnas.71.12.4864
Hong JK, Lakshmanan M, Goudar C, Lee DY (2018) Towards next generation CHO cell line development and engineering by systems approaches. Curr Opin Chem Eng 22:1–10. https://doi.org/10.1016/j.coche.2018.08.002
Hosaka A, Kakutani T (2018) Transposable elements, genome evolution and transgenerational epigenetic variation. Curr Opin Genet Dev 49:43–48. https://doi.org/10.1016/j.gde.2018.02.012
Huberts DH, Janssens GE, Lee SS, Vizcarra IA, Heinemann M (2013) Continuous high-resolution microscopic observation of replicative aging in budding yeast. JoVE J Visual Exp 78:e50143. https://doi.org/10.3791/50143
Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE (2018) A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol 19(12):755–773. https://doi.org/10.1038/s41580-018-0060-8
Jahn TR, Makin OS, Morris KL, Marshall KE, Tian P, Sikorski P, Serpell LC (2010) The common architecture of cross-β amyloid. J Mol Biol 395(4):717–727. https://doi.org/10.1016/j.jmb.2009.09.039
Karathia H, Vilaprinyo E, Sorribas A, Alves R (2011) Saccharomyces cerevisiae as a model organism: a comparative study. PLoS ONE 6(2):e16015. https://doi.org/10.1371/journal.pone.0016015
Kay LE (1985) Conceptual models and analytical tools: The biology of physicist Max Delbrück. J Hist Biol 18(2):207–246. https://doi.org/10.1007/BF00120110
Keller PJ (2013) Imaging morphogenesis: technological advances and biological insights. Science 340(6137):1234168. https://doi.org/10.1126/science.1234168
Kennedy BK, Austriaco NR Jr, Guarente L (1994) Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life span. J Cell Biol 127(6):1985–1993. https://doi.org/10.1083/jcb.127.6.1985
Khokhlov AN (2016) Which aging in yeast is “true”? Mosc Univ Biol Sci Bull 71(1):11–13. https://doi.org/10.3103/S009639251601003X
King CY, Diaz-Avalos R (2004) Protein-only transmission of three yeast prion strains. Nature 428(6980):319–323. https://doi.org/10.1038/nature02391
King CY, Tittmann P, Gross H, Gebert R, Aebi M, Wüthrich K (1997) Prion-inducing domain 2–114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci 94(13):6618–6622. https://doi.org/10.1073/pnas.94.13.6618
Klaips CL, Jayaraj GG, Hartl FU (2018) Pathways of cellular proteostasis in aging and disease. J Cell Biol 217(1):51–63. https://doi.org/10.1083/jcb.201709072
Kota SK, Feil R (2010) Epigenetic transitions in germ cell development and meiosis. Dev Cell 19(5):675–686. https://doi.org/10.1016/j.devcel.2010.10.009
Kreft JU, Booth G, Wimpenny JW (1998) BacSim, a simulator for individual-based modelling of bacterial colony growth. Microbiology 144(12):3275–3287. https://doi.org/10.1099/00221287-144-12-3275
Labbadia J, Morimoto RI (2015) The biology of proteostasis in aging and disease. Annu Rev Biochem 84:435. https://doi.org/10.1146/annurev-biochem-060614-033955
Lacroute F (1971) Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J Bacteriol 106(2):519–522. https://doi.org/10.1128/jb.106.2.519-522.1971
Lansbury PT, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, Kocisko DA, Hendsch ZS, Ashburn TT, Spencer RG, Tidor B (1995) Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol 2(11):990–998. https://doi.org/10.1038/nsb1195-990
Laszlo JA, Silman RW (1993) Cellular automata simulations of fungal growth on solid substrates. Biotechnol Adv 11(3):621–633. https://doi.org/10.1016/0734-9750(93)90031-H
Leach AR (2001) Chapter 8: Monte Carlo methods. Molecular modelling: principles and applications. Pearson Education, London, pp 410–454
Lee Y, Kouvroukoglou S, McIntire LV, Zygourakis K (1995) A cellular automaton model for the proliferation of migrating contact-inhibited cells. Biophys J 69(4):1284–1298. https://doi.org/10.1016/S0006-3495(95)79996-9
Lemarre P, Pujo-Menjouet L, Sindi SS (2020) A unifying model for the propagation of prion proteins in yeast brings insight into the [PSI+] prion. PLoS Computat Biol 16(5):e1007647. https://doi.org/10.1371/journal.pcbi.1007647
Liberski PP (2012) Historical overview of prion diseases: a view from afar. Folia Neuropathol 50(1):1–12
Lim JP, Brunet A (2013) Bridging the transgenerational gap with epigenetic memory. Trends Genet 29(3):176–186. https://doi.org/10.1016/j.tig.2012.12.008
Longo VD, Fabrizio P (2011) Chronological aging in Saccharomyces cerevisiae. Aging Res Yeast. https://doi.org/10.1007/978-94-007-2561-4_5
Longo VD, Shadel GS, Kaeberlein M, Kennedy B (2012) Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab 16(1):18–31. https://doi.org/10.1016/j.cmet.2012.06.002
Lord PG, Wheals AE (1980) Asymmetrical division of Saccharomyces cerevisiae. J Bacteriol 142(3):808–818. https://doi.org/10.1128/jb.142.3.808-818.1980
Louis EJ (2016) Historical evolution of laboratory strains of Saccharomyces cerevisiae. Cold Spring Harbor Protoc 2016(7):pdb-top077750. https://doi.org/10.1101/pdb.top077750
Lücking CB (2000) Alpha-synuclein and Parkinson’s disease. Cell Mol Life Sci CMLS 57(13):1894–1908. https://doi.org/10.1007/PL00000671
Manjrekar J (2017) Epigenetic inheritance, prions and evolution. J Genet 96(3):445–456. https://doi.org/10.1007/s12041-017-0798-3
Marchante R, Beal DM, Koloteva-Levine N, Purton TJ, Tuite MF, Xue WF (2017) The physical dimensions of amyloid aggregates control their infective potential as prion particles. Elife. https://doi.org/10.7554/eLife.27109
Martinez-Naharro A, Hawkins PN, Fontana M (2018) Cardiac amyloidosis. Clin Med 18(Suppl 2):s30. https://doi.org/10.7861/clinmedicine.18-2s-s30
Masel J, Jansen VA, Nowak MA (1999) Quantifying the kinetic parameters of prion replication. Biophys Chem 77(2–3):139–152. https://doi.org/10.1016/S0301-4622(99)00016-2
Masison DC, Maddelein ML, Wickner RB (1997) The prion model for [URE3] of yeast: spontaneous generation and requirements for propagation. Proc Natl Acad Sci 94(23):12503–12508. https://doi.org/10.1073/pnas.94.23.12503
Matthäus F (2006) Diffusion versus network models as descriptions for the spread of prion diseases in the brain. J Theor Biol 240(1):104–113. https://doi.org/10.1016/j.jtbi.2005.08.030
Mayhew MB, Iversen ES, Hartemink AJ (2017) Characterization of dependencies between growth and division in budding yeast. J R Soc Interface 14(127):20160993. https://doi.org/10.1098/rsif.2016.0993
McFaline-Figueroa JR, Vevea J, Swayne TC, Zhou C, Liu C, Leung G, Boldogh IR, Pon LA (2011) Mitochondrial quality control during inheritance is associated with lifespan and mother–daughter age asymmetry in budding yeast. Aging Cell 10(5):885–895. https://doi.org/10.1111/j.1474-9726.2011.00731.x
McGlinchey RP, Kryndushkin D, Wickner RB (2011) Suicidal [PSI+] is a lethal yeast prion. Proc Natl Acad Sci 108(13):5337–5341. https://doi.org/10.1073/pnas.1102762108
Meier BH, Riek R, Böckmann A (2017) Emerging structural understanding of amyloid fibrils by solid-state NMR. Trends Biochem Sci 42(10):777–787. https://doi.org/10.1038/nnano.2010.59
Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349(6):583–596. https://doi.org/10.1056/NEJMra023144
Miller SB, Mogk A, Bukau B (2015) Spatially organized aggregation of misfolded proteins as cellular stress defense strategy. J Mol Biol 427(7):1564–1574. https://doi.org/10.1016/j.jmb.2015.02.006
Misgeld T, Schwarz TL (2017) Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron 96(3):651–666. https://doi.org/10.1016/j.neuron.2017.09.055
Mitchison JM (1971) Biology of the cell cycle. Cambridge University Press, London
Moore TA, Li A, Young EW (2018) Integrating population heterogeneity indices with microfluidic cell-based assays. SLAS Discov Adv Sci Drug Disc 23(5):459–473. https://doi.org/10.1177/2472555217738533
Morange M (2000) A history of molecular biology. Part 1. The birth of molecular biology. Harvard University Press, Cambridge, pp 11–103
Nagel L (1946) A cytological study of yeast (Saccharomyces cerevisiae). Ann Mo Bot Gard 33(3):249–289. https://doi.org/10.2307/2394451
Nakagawa Y, Shen C-h, Komi Y, Sugiyama S, Kurinomaru T, Tomabechi Y, Krayukhina E, Okamoto K, Yokoyama T, Shirouzu M, Uchiyama S, Inaba M, Niwa T, Sako Y, Taguchi H, Tanaka M (2022) Amyloid conformation-dependent disaggregation in a reconstituted yeast prion system. Nat Chem Biol 18:321–331. https://doi.org/10.1038/s41589-021-00951-y
Nizynski B, Dzwolak W, Nieznanski K (2017) Amyloidogenesis of Tau protein. Protein Sci 26(11):2126–2150. https://doi.org/10.1002/pro.3275
Nowak MA, Krakauer DC, Klug A, May RM (1998) Prion infection dynamics. Integr Biol Issues News Rev Publ Assoc Soc Integr Comp Biol 1(1):3–15. https://doi.org/10.1002/(SICI)1520-6602(1998)1:1%3c3::AID-INBI2%3e3.0.CO;2-9
O’Kane CJ, Hyland EM (2019) Yeast epigenetics: the inheritance of histone modification states. Biosci Rep 39(5):BSR20182006. https://doi.org/10.1042/BSR20182006
Oates AC, Gorfinkiel N, Gonzalez-Gaitan M, Heisenberg CP (2009) Quantitative approaches in developmental biology. Nat Rev Genet 10(8):517–530. https://doi.org/10.1038/nrg2548
Ohtsuka K, Suzuki T (2000) Roles of molecular chaperones in the nervous system. Brain Res Bull 53(2):141–146. https://doi.org/10.1016/S0361-9230(00)00325-7
Oosawa F, Asakura S (1975) Thermodynamics of the polymerization of protein. Academic Press, Cambridge
Oosawa F, Kasai M (1962) A theory of linear and helical aggregations of macromolecules. J Mol Biol 4(1):10–21. https://doi.org/10.1016/S0022-2836(62)80112-0
Pallitto MM, Murphy RM (2001) A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state. Biophys J 81(3):1805–1822. https://doi.org/10.1016/S0006-3495(01)75831-6
Patel BK, Liebman SW (2007) “Prion-proof” for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132–405) induces [PIN+]. J Mol Biol 365(3):773–782. https://doi.org/10.1016/j.jmb.2006.10.069
Patino MM, Liu JJ, Glover JR, Lindquist S (1996) Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273(5275):622–626. https://doi.org/10.1126/science.273.5275.622
Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1996) Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J 15:3127–3134. https://doi.org/10.1002/j.1460-2075.1996.tb00675.x
Picken MM (2020) The pathology of amyloidosis in classification: a review. Acta Haematol 143(4):322–334. https://doi.org/10.1159/000506696
Poser CM (2002a) Notes on the history of the prion diseases. Part I. Clin Neurol Neurosurg 104(1):1–9. https://doi.org/10.1016/S0303-8467(01)00186-X
Poser CM (2002b) Notes on the history of the prion diseases. Part II. Clin Neurol Neurosurg 104(2):77–86. https://doi.org/10.1016/S0303-8467(01)00200-1
Poynton CA (1998) Rehabilitation of gamma. Human vision and electronic imaging III, vol 3299. SPIE, San Jose, pp 232–249
Press WH, Teukolsky SA, Vetterling WT, Flannery BP (2007) Chapter 16: Integration of ordinary differential equations. Numerical recipes in C++. The art of scientific computing. Cambridge University Press, Cambridge, pp 707–747
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542):136–144. https://doi.org/10.1126/science.68017
Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, Glenner GG (1983) Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35(2):349–358. https://doi.org/10.1016/0092-8674(83)90168-X
Rasmussen AK, Chatterjee A, Rasmussen LJ, Singh KK (2003) Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nucleic Acids Res 31(14):3909–3917. https://doi.org/10.1093/nar/gkg446
Razin A, Riggs AD (1980) DNA methylation and gene function. Science 210(4470):604–610. https://doi.org/10.1126/science.6254144
Riggi N, Aguet M, Stamenkovic I (2018) Cancer metastasis: a reappraisal of its underlying mechanisms and their relevance to treatment. Annu Rev Pathol 13:117–140. https://doi.org/10.1146/annurev-pathol-020117-044127
Riggs A, Martienssen V, Russo V (1996). In: Russo VE, Martienssen RA, Riggs AD (eds) Epigenetic mechanisms of gene regulation, vol 32. Cold Spring Harbor Laboratory Press, New York, p 1
Ringe D, Petsko GA (2009) Q&A: What are pharmacological chaperones and why are they interesting? J Biol 8(9):1–4. https://doi.org/10.1186/jbiol186
Rivas EM, Gil de Prado E, Wrent P, de Silóniz MI, Barreiro P, Correa EC, Conejero F, Murciano A, Peinado JM (2014) A simple mathematical model that describes the growth of the area and the number of total and viable cells in yeast colonies. Lett Appl Microbiol 59(6):594–603. https://doi.org/10.1111/lam.12314
Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10(1):83–98. https://doi.org/10.1016/S1474-4422(10)70245-3
Roy AMIT, Lu CF, Marykwas DL, Lipke PN, Kurjan J (1991) The AGA1 product is involved in cell surface attachment of the Saccharomyces cerevisiae cell adhesion glycoprotein a-agglutinin. Mol Cell Biol. https://doi.org/10.1128/mcb.11.8.4196-4206.1991
Ruusuvuori P, Lin J, Scott AC, Tan Z, Sorsa S, Kallio A, Nykter M, Yli-Harja O, Shmulevich I, Dudley AM (2014) Quantitative analysis of colony morphology in yeast. Biotechniques 56(1):18–27. https://doi.org/10.2144/000114123
Scheper T, Hoffmann H, Schügerl K (1987) Flow cytometric studies during culture of Saccharomyces cerevisiae. Enzyme Microb Technol 9(7):399–405. https://doi.org/10.1016/0141-0229(87)90134-7
Schlumpberger M, Prusiner SB, Herskowitz I (2001) Induction of distinct [URE3] yeast prion strains. Mol Cell Biol 21(20):7035–7046. https://doi.org/10.1128/MCB.21.20.7035-7046.2001
Serio TR, Cashikar AG, Moslehi JJ, Kowal AS, Lindquist SL (1999) [41] Yeast prion [Ψ+] and its determinant, sup35p. Methods in enzymology, vol 309. Academic Press, Cambridge, pp 649–673
Shah NA, Laws RJ, Wardman B, Zhao LP, Hartman JL (2007) Accurate, precise modeling of cell proliferation kinetics from time-lapse imaging and automated image analysis of agar yeast culture arrays. BMC Syst Biol 1(1):1–14. https://doi.org/10.1186/1752-0509-1-3
Sharma J, Liebman SW (2012) [PSI+] prion variant establishment in yeast. Mol Microbiol 86(4):866–881. https://doi.org/10.1111/mmi.12024
Singal R, Ginder GD (1999) DNA methylation. Blood J Am Soc Hematol 93(12):4059–4070. https://doi.org/10.1182/blood.V93.12.4059
Sipe JD, Cohen AS (2000) History of the amyloid fibril. J Struct Biol 130(2–3):88–98. https://doi.org/10.1006/jsbi.2000.4221
Snijder B, Pelkmans L (2011) Origins of regulated cell-to-cell variability. Nat Rev Mol Cell Biol 12(2):119–125. https://doi.org/10.1038/nrm3044
Soifer I, Robert L, Amir A (2016) Single-cell analysis of growth in budding yeast and bacteria reveals a common size regulation strategy. Curr Biol 26(3):356–361. https://doi.org/10.1016/j.cub.2015.11.067
Son M, Wickner RB (2022) Antiprion systems in yeast cooperate to cure or prevent the generation of nearly all [PSI+] and [URE3] prions. Proc Natl Acad Sci 119(28):e2205500119. https://doi.org/10.1073/pnas.2205500119
Sondheimer N, Lindquist S (2000) Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell 5(1):163–172. https://doi.org/10.1016/S1097-2765(00)80412-8
Sparrer HE, Santoso A, Szoka FC Jr, Weissman JS (2000) Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein. Science 289(5479):595–599. https://doi.org/10.1126/science.289.5479.595
St Johnston D (1995) The intracellular localization of messenger RNAs. Cell 81(2):161–170. https://doi.org/10.1016/0092-8674(95)90324-0
Stansfield I, Jones KM, Kushnirov VV, Dagkesamanskaya AR, Poznyakovski AI, Paushkin SV, Nierras CR, Cox BS, Ter-Avanesyan MD, Tuite MF (1995) The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J 14(17):4365–4373. https://doi.org/10.1002/j.1460-2075.1995.tb00111.x
Steiner JA, Angot E, Brundin P (2011) A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death Differ 18(9):1425–1433. https://doi.org/10.1038/cdd.2011.53
Steinkraus KA, Kaeberlein M, Kennedy BK (2008) Replicative aging in yeast: the means to the end. Annu Rev Cell Dev Biol 24:29–54. https://doi.org/10.1146/annurev.cellbio.23.090506.123509
Stevens JL, Baker TK (2009) The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov Today 14(3–4):162–167. https://doi.org/10.1016/j.drudis.2008.11.009
Stockholm D, Benchaouir R, Picot J, Rameau P, Neildez TMA, Landini G, Laplace-Builhé C, Paldi A (2007) The origin of phenotypic heterogeneity in a clonal cell population in vitro. PLoS ONE 2(4):e394. https://doi.org/10.1371/journal.pone.0000394
Summers DW, Cyr DM (2011) Use of yeast as a system to study amyloid toxicity. Methods 53(3):226–231. https://doi.org/10.1016/j.ymeth.2010.11.007
Suzuki K, Ohsumi Y (2007) Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 581(11):2156–2161. https://doi.org/10.1016/j.febslet.2007.01.096
Tanaka M, Collins SR, Toyama BH, Weissman JS (2006) The physical basis of how prion conformations determine strain phenotypes. Nature 442(7102):585–589. https://doi.org/10.1038/nature04922
Tang Y, Gao XD, Wang Y, Yuan BF, Feng YQ (2012) Widespread existence of cytosine methylation in yeast DNA measured by gas chromatography/mass spectrometry. Anal Chem 84(16):7249–7255. https://doi.org/10.1021/ac301727c
Tuite MF (2015) Yeast prions: Paramutation at the protein level?. In Seminars in cell & developmental biology (Vol. 44, pp. 51-61). Academic Press. https://doi.org/10.1016/j.semcdb.2015.08.016
Tuite MF, Serio TR (2010) The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 11(12):823–833. https://doi.org/10.1038/nrm3007
Tuite MF, Cox BS, McLaughlin CS (1983) In vitro nonsense suppression in [PSI+] and [PSI−] cell-free lysates of Saccharomyces cerevisiae. Proc Natl Acad Sci 80(10):2824–2828. https://doi.org/10.1073/pnas.80.10.282
Tuite MF, Staniforth GL, Cox BS (2015) [PSI+] turns 50. Prion 9(5):318–332. https://doi.org/10.1080/19336896.2015.1111508
Vanoni M, Vai M, Popolo L, Alberghina L (1983) Structural heterogeneity in populations of the budding yeast Saccharomyces cerevisiae. J Bacteriol 156(3):1282–1291. https://doi.org/10.1128/jb.156.3.1282-1291.1983
Verghese J, Abrams J, Wang Y, Morano KA (2012) Biology of the heat shock response and protein chaperones: budding yeast (Saccharomyces cerevisiae) as a model system. Microbiol Mol Biol Rev 76(2):115–158. https://doi.org/10.1128/MMBR.05018-11
Verstrepen KJ, Klis FM (2006) Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 60(1):5–15. https://doi.org/10.1111/j.1365-2958.2006.05072.x
Vevea JD, Swayne TC, Boldogh IR, Pon LA (2014) Inheritance of the fittest mitochondria in yeast. Trends Cell Biol 24(1):53–60. https://doi.org/10.1016/j.tcb.2013.07.003
Vulin C, Di Meglio JM, Lindner AB, Daerr A, Murray A, Hersen P (2014) Growing yeast into cylindrical colonies. Biophys J 106(10):2214–2221. https://doi.org/10.1016/j.bpj.2014.02.040
Waddington CH (1942) The epigenotype. Endeavour 1:18–20. https://doi.org/10.1093/ije/dyr184. (Reprinted within International Journal of Epidemiology 2012;41:10–13)
Wang K, Melki R, Kabani M (2017) A prolonged chronological lifespan is an unexpected benefit of the [PSI+] prion in yeast. PLoS ONE 12(9):e0184905. https://doi.org/10.1371/journal.pone.0184905
Wegner A, Engel J (1975) Kinetics of the cooperative association of actin to actin filament. Biophys Chem 3(3):215–225. https://doi.org/10.1016/0301-4622(75)80013-5
Wegrzyn RD, Bapat K, Newnam GP, Zink AD, Chernoff YO (2001) Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol 21(14):4656–4669. https://doi.org/10.1128/MCB.21.14.4656-4669.2001
Weickenmeier J, Kuhl E, Goriely A (2018) Multiphysics of prionlike diseases: Progression and atrophy. Phys Rev Lett 121(15):158101. https://doi.org/10.1103/PhysRevLett.121.158101
Weissbach A (2013). In: Jost J, Saluz H (eds) DNA methylation: molecular biology and biological significance, vol 64. Basel, Birkhäuser, pp 1–11
Weissmann C (1991) A “unified theory” of prion propagation. Nature 352(6337):679–683. https://doi.org/10.1038/352679a0
Wentink A, Nussbaum-Krammer C, Bukau B (2019) Modulation of amyloid states by molecular chaperones. Cold Spring Harbor Perspect Biol 11(7):a033969. https://doi.org/10.1101/cshperspect.a033969
Wickner RB (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566–569. https://doi.org/10.1126/science.7909170
Wickner RB, Leibowitz MJ (1977) Dominant chromosomal mutation bypassing chromosomal genes needed for killer RNA plasmid replication in yeast. Genetics 87(3):453–469. https://doi.org/10.1093/genetics/87.3.453
Wickner RB, Masison DC, Edskes HK (1995) [PSI] and [URE3] as yeast prions. Yeast 11(16):1671–1685. https://doi.org/10.1002/yea.320111609
Wickner RB, Taylor KL, Edskes HK, Maddelein ML, Moriyama H, Roberts BT (1999) Prions in Saccharomyces and Podospora spp.: protein-based inheritance. Microbiol Mol Biology Rev 63(4):844–861. https://doi.org/10.1128/MMBR.63.4.844-861.1999
Wickner RB, Edskes HK, Bateman D, Kelly AC, Gorkovskiy A (2011) The yeast prions [PSI+] and [URE3] are molecular degenerative diseases. Prion 5(4):258–262. https://doi.org/10.4161/pri.17748
Wickner RB, Bezsonov E, Bateman DA (2014) Normal levels of the antiprion proteins Btn2 and Cur1 cure most newly formed [URE3] prion variants. Proc Natl Acad Sci 111(26):E2711–E2720. https://doi.org/10.1073/pnas.1409582111
Wickner RB, Shewmaker FP, Bateman DA, Edskes HK, Gorkovskiy A, Dayani Y, Bezsonov EE (2015) Yeast prions: structure, biology, and prion-handling systems. Microbiol Mol Biol Rev 79(1):1–17. https://doi.org/10.1128/MMBR.00041-14
Wickner RB, Edskes HK, Son M, Wu S, Niznikiewicz M (2021) Innate immunity to prions: anti-prion systems turn a tsunami of prions into a slow drip. Curr Genet 67(6):833–847. https://doi.org/10.1007/s00294-021-01203-1
Woodworth MB, Girskis KM, Walsh CA (2017) Building a lineage from single cells: genetic techniques for cell lineage tracking. Nat Rev Genet 18(4):230–244. https://doi.org/10.1038/nrg.2016.159
Xue WF, Homans SW, Radford SE (2008) Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci 105(26):8926–8931. https://doi.org/10.1073/pnas.0711664105
Yang J, McCormick MA, Zheng J, Xie Z, Tsuchiya M, Tsuchiyama S, El-Samad H, Ouyang Q, Kaeberlein M, Kennedy BK, Li H (2015) Systematic analysis of asymmetric partitioning of yeast proteome between mother and daughter cells reveals “aging factors” and mechanism of lifespan asymmetry. Proc Natl Acad Sci 112(38):11977–11982. https://doi.org/10.1073/pnas.1506054112
Zhao R, So M, Maat H, Ray NJ, Arisaka F, Goto Y, Carver JA, Hall D (2016) Measurement of amyloid formation by turbidity assay—seeing through the cloud. Biophys Rev 8(4):445–471. https://doi.org/10.1007/s12551-016-0233-7
Zhao X, Lanz J, Steinberg D, Pease T, Ahearn JM, Bezsonov EE, Staguhn ED, Eisenberg E, Masison DC, Greene LE (2018) Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion. J Biol Chem 293(9):3104–3117. https://doi.org/10.1074/jbc.M117.809079
Zou S, Ke N, Kim JM, Voytas DF (1996) The Saccharomyces retrotransposon Ty5 integrates preferentially into regions of silent chromatin at the telomeres and mating loci. Genes Dev 10(5):634–645. https://doi.org/10.1101/gad.10.5.634
Acknowledgements
DH would like to thank Profs. A.S. Foster, O. Silveira Junior, J. Harris, H. Edskes, M. Okada, K. Ohnuma, K. Shearwin, T. Sumikama, H. Flechsig, C. Franz, K. Nagayama, R. Wickner, A. Kinjo and H. Nakamura for a series of helpful written comments on an earlier draft of this work. DH would also like to thank Dr. Reed Wickner and Dr. Daniel Masison (and their associated laboratory members) for helpful discussion at the outset of this work. DH acknowledges funding associated with the receipt of a ‘Tokunin’ Assistant Professorship carried out at the WPI-Center for Nano Life Science, Kanazawa University. This work was supported, in part, by KAKENHI Start-Up grant 21K20633, KAKENHI Kiban-C grant 23K05712 and WPI ‘Funds in Aid of Research’ grant awarded to D.H.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
DH reports no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
MIL-CELL download https://drive.google.com/drive/folders/1xNBSL_2sGNkyXfYLYUyXjyM9ibGAcQUL?usp=sharing.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hall, D. MIL-CELL: a tool for multi-scale simulation of yeast replication and prion transmission. Eur Biophys J 52, 673–704 (2023). https://doi.org/10.1007/s00249-023-01679-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-023-01679-4